WO2022196798A1 - Device for controlling biometric function via light stimulation and operation method thereof - Google Patents
Device for controlling biometric function via light stimulation and operation method thereof Download PDFInfo
- Publication number
- WO2022196798A1 WO2022196798A1 PCT/JP2022/012620 JP2022012620W WO2022196798A1 WO 2022196798 A1 WO2022196798 A1 WO 2022196798A1 JP 2022012620 W JP2022012620 W JP 2022012620W WO 2022196798 A1 WO2022196798 A1 WO 2022196798A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- light
- light source
- living body
- specific wavelength
- irradiating
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 177
- 230000000638 stimulation Effects 0.000 title claims abstract description 71
- 230000004397 blinking Effects 0.000 claims abstract description 98
- 230000001678 irradiating effect Effects 0.000 claims description 100
- 230000000694 effects Effects 0.000 claims description 82
- 230000001737 promoting effect Effects 0.000 claims description 80
- 230000008827 biological function Effects 0.000 claims description 71
- 230000036760 body temperature Effects 0.000 claims description 52
- 239000008280 blood Substances 0.000 claims description 47
- 210000004369 blood Anatomy 0.000 claims description 47
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 44
- 239000008103 glucose Substances 0.000 claims description 44
- 230000004913 activation Effects 0.000 claims description 43
- 230000003727 cerebral blood flow Effects 0.000 claims description 40
- 230000002490 cerebral effect Effects 0.000 claims description 39
- 210000005037 parasympathetic nerve Anatomy 0.000 claims description 32
- 230000003860 sleep quality Effects 0.000 claims description 32
- 230000001965 increasing effect Effects 0.000 claims description 31
- 235000019786 weight gain Nutrition 0.000 claims description 30
- 230000009467 reduction Effects 0.000 claims description 29
- 230000004584 weight gain Effects 0.000 claims description 29
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 28
- 229910052760 oxygen Inorganic materials 0.000 claims description 28
- 239000001301 oxygen Substances 0.000 claims description 28
- 238000011282 treatment Methods 0.000 claims description 25
- 230000003287 optical effect Effects 0.000 claims description 22
- 230000001629 suppression Effects 0.000 claims description 22
- 238000004590 computer program Methods 0.000 claims description 19
- 230000006870 function Effects 0.000 claims description 12
- 230000006872 improvement Effects 0.000 claims description 10
- 230000002631 hypothermal effect Effects 0.000 claims description 9
- 238000006213 oxygenation reaction Methods 0.000 claims description 9
- 230000008701 parasympathetic activation Effects 0.000 claims description 6
- 230000001276 controlling effect Effects 0.000 description 46
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 27
- 201000010099 disease Diseases 0.000 description 26
- 208000019116 sleep disease Diseases 0.000 description 26
- 206010012601 diabetes mellitus Diseases 0.000 description 16
- 230000007423 decrease Effects 0.000 description 15
- 230000003449 preventive effect Effects 0.000 description 15
- 230000032683 aging Effects 0.000 description 14
- 230000037396 body weight Effects 0.000 description 14
- 230000002265 prevention Effects 0.000 description 14
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 13
- 230000003405 preventing effect Effects 0.000 description 13
- 208000019888 Circadian rhythm sleep disease Diseases 0.000 description 12
- 206010010774 Constipation Diseases 0.000 description 12
- 208000001456 Jet Lag Syndrome Diseases 0.000 description 12
- 206010041349 Somnolence Diseases 0.000 description 12
- 239000011521 glass Substances 0.000 description 12
- 208000033915 jet lag type circadian rhythm sleep disease Diseases 0.000 description 12
- 230000035882 stress Effects 0.000 description 12
- 206010003210 Arteriosclerosis Diseases 0.000 description 11
- 206010013774 Dry eye Diseases 0.000 description 11
- 201000005569 Gout Diseases 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 11
- 208000008589 Obesity Diseases 0.000 description 11
- 208000011775 arteriosclerosis disease Diseases 0.000 description 11
- 208000021921 corneal disease Diseases 0.000 description 11
- 235000020824 obesity Nutrition 0.000 description 11
- 102000001554 Hemoglobins Human genes 0.000 description 10
- 108010054147 Hemoglobins Proteins 0.000 description 10
- 230000001684 chronic effect Effects 0.000 description 10
- 230000002438 mitochondrial effect Effects 0.000 description 10
- 230000001225 therapeutic effect Effects 0.000 description 10
- 239000012530 fluid Substances 0.000 description 9
- 230000004060 metabolic process Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 7
- 206010008118 cerebral infarction Diseases 0.000 description 6
- 208000026106 cerebrovascular disease Diseases 0.000 description 6
- 230000006806 disease prevention Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 208000006011 Stroke Diseases 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 206010062519 Poor quality sleep Diseases 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 208000017169 kidney disease Diseases 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- 238000011017 operating method Methods 0.000 description 4
- 238000004260 weight control Methods 0.000 description 4
- 230000003579 anti-obesity Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000002554 disease preventive effect Effects 0.000 description 3
- 230000000004 hemodynamic effect Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 208000001491 myopia Diseases 0.000 description 3
- 230000004379 myopia Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000008667 sleep stage Effects 0.000 description 3
- 208000020685 sleep-wake disease Diseases 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 208000031636 Body Temperature Changes Diseases 0.000 description 2
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 238000004497 NIR spectroscopy Methods 0.000 description 2
- 206010034972 Photosensitivity reaction Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000002060 circadian Effects 0.000 description 2
- 230000027288 circadian rhythm Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- SSQPWTVBQMWLSZ-AAQCHOMXSA-N ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate Chemical compound CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC SSQPWTVBQMWLSZ-AAQCHOMXSA-N 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 2
- 229960002600 icosapent ethyl Drugs 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 2
- 230000036211 photosensitivity Effects 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 230000004489 tear production Effects 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 208000006888 Agnosia Diseases 0.000 description 1
- 241001047040 Agnosia Species 0.000 description 1
- 102000008873 Angiotensin II receptor Human genes 0.000 description 1
- 108050000824 Angiotensin II receptor Proteins 0.000 description 1
- 206010003062 Apraxia Diseases 0.000 description 1
- UMSGKTJDUHERQW-UHFFFAOYSA-N Brotizolam Chemical compound C1=2C=C(Br)SC=2N2C(C)=NN=C2CN=C1C1=CC=CC=C1Cl UMSGKTJDUHERQW-UHFFFAOYSA-N 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- ZPXSCAKFGYXMGA-UHFFFAOYSA-N Mazindol Chemical compound N12CCN=C2C2=CC=CC=C2C1(O)C1=CC=C(Cl)C=C1 ZPXSCAKFGYXMGA-UHFFFAOYSA-N 0.000 description 1
- 206010027590 Middle insomnia Diseases 0.000 description 1
- 208000009433 Moyamoya Disease Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- NMLMACJWHPHKGR-NCOIDOBVSA-N P(1),P(4)-bis(uridin-5'-yl) tetraphosphate Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@H]2O)O)COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N2C(NC(=O)C=C2)=O)O)O)C=CC(=O)NC1=O NMLMACJWHPHKGR-NCOIDOBVSA-N 0.000 description 1
- IKMPWMZBZSAONZ-UHFFFAOYSA-N Quazepam Chemical compound FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=CC=C(Cl)C=C12 IKMPWMZBZSAONZ-UHFFFAOYSA-N 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041235 Snoring Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000000883 anti-obesity agent Substances 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229960003051 brotizolam Drugs 0.000 description 1
- 235000020827 calorie restriction Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 229940090124 dipeptidyl peptidase 4 (dpp-4) inhibitors for blood glucose lowering Drugs 0.000 description 1
- 229950003529 diquafosol Drugs 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002336 estazolam Drugs 0.000 description 1
- CDCHDCWJMGXXRH-UHFFFAOYSA-N estazolam Chemical compound C=1C(Cl)=CC=C(N2C=NN=C2CN=2)C=1C=2C1=CC=CC=C1 CDCHDCWJMGXXRH-UHFFFAOYSA-N 0.000 description 1
- 230000004424 eye movement Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229960005101 febuxostat Drugs 0.000 description 1
- BQSJTQLCZDPROO-UHFFFAOYSA-N febuxostat Chemical compound C1=C(C#N)C(OCC(C)C)=CC=C1C1=NC(C)=C(C(O)=O)S1 BQSJTQLCZDPROO-UHFFFAOYSA-N 0.000 description 1
- 229940125753 fibrate Drugs 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 210000001652 frontal lobe Anatomy 0.000 description 1
- 230000004313 glare Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229960000299 mazindol Drugs 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 1
- 229960001243 orlistat Drugs 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 210000002442 prefrontal cortex Anatomy 0.000 description 1
- FYPMFJGVHOHGLL-UHFFFAOYSA-N probucol Chemical compound C=1C(C(C)(C)C)=C(O)C(C(C)(C)C)=CC=1SC(C)(C)SC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 FYPMFJGVHOHGLL-UHFFFAOYSA-N 0.000 description 1
- 229960003912 probucol Drugs 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229960001964 quazepam Drugs 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 150000003548 thiazolidines Chemical class 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M21/02—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0618—Psychological treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0622—Optical stimulation for exciting neural tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0044—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the sight sense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
- A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
- A61N2005/0648—Applicators worn by the patient the applicator adapted to be worn on the head the light being directed to the eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
- A61N2005/0663—Coloured light
Definitions
- the present invention provides a device and method for controlling biological functions, a device and method for promoting increase in tear volume, and a device and method for improving sleep efficiency or sleep quality by light stimulation by irradiating light of a specific wavelength such as violet light at a specific flickering frequency.
- a specific wavelength such as violet light at a specific flickering frequency.
- blood glucose concentration reduction or increase suppression device and method weight gain suppression device and method, cerebral blood flow and cerebral oxygen concentration increase enhancement device and method, and light environment improvement device and method.
- Non-Patent Document 1 exposure to sunlight improves circadian rhythms (Non-Patent Document 1), and light emitted from LED lighting and liquid crystal displays using LEDs as backlights has a significant effect on the body and mind (Non-Patent Document 1). 2) It has been reported that violet light prevents myopia and suppresses the onset of myopia (Patent Document 1). Particularly recently, the present inventors have made interesting reports about the effects of violet light on the eyes. It has been proposed that the myopia population is still increasing worldwide, and there are great expectations in recent years.
- the present invention is based on the findings that the inventors have found that irradiation with light of a specific wavelength, especially violet light (visible light in the range of 360 to 400 nm), at a blinking frequency causes various effects on living organisms. It is the result obtained by further investigation, and the purpose is a biological function control device and method by optical stimulation by irradiating light of a specific wavelength such as violet light at a constant light or a specific blinking frequency, and an increase in the amount of lacrimal fluid.
- a specific wavelength especially violet light (visible light in the range of 360 to 400 nm)
- the purpose is a biological function control device and method by optical stimulation by irradiating light of a specific wavelength such as violet light at a constant light or a specific blinking frequency, and an increase in the amount of lacrimal fluid.
- An object of the present invention is to provide an increase promoting device and method, a parasympathetic nerve activation promoting device and method, and a light environment improving device and method.
- Another object of the present invention is to improve or prevent a disease or condition related to tear volume, improve or prevent a disease or condition related to sleep efficiency or sleep quality by irradiating a violet light with a constant light or a specific blinking frequency.
- amelioration or prevention, amelioration or prevention of diseases or conditions related to blood glucose level, amelioration or prevention of diseases or conditions related to body temperature, amelioration or prevention of diseases or conditions related to body weight, cerebral blood flow and cerebral oxygen concentration The purpose of the present invention is to provide a method or device for amelioration or prevention of diseases or conditions related to the parasympathetic nervous system, and amelioration or prevention of diseases or conditions related to parasympathetic nerves.
- a further object of the present invention is to provide a method and apparatus for improving the indoor environment by irradiating light of a specific wavelength such as violet light at a constant light or at a specific flickering frequency.
- the apparatus for controlling biological functions by optical stimulation is an apparatus for controlling biological functions by irradiating a living body (for example, mammals including humans) with light of a specific wavelength at a constant light or a specific blinking frequency
- the apparatus is characterized by comprising a light source that emits the light of the specific wavelength at a constant light or at a specific flickering frequency, and a controller that controls emission of the light that controls the biological function of the living body that receives the light.
- the control of biological function is control of body temperature, body temperature control, body weight control, blood glucose level control, tear volume control, parasympathetic nerve activation control , control of sleep efficiency or quality, control of cerebral blood flow and cerebral oxygenation, but are not limited thereto.
- various stimuli can be given to the living body or the functions of the living body can be enhanced by controlling the irradiation state of the light. can.
- a disease or condition related to biological functions it can be applied to various mental and physical improving effects and therapeutic effects resulting therefrom.
- the light is, for example, violet light.
- the living body can be irradiated with violet light having a wavelength outside the visible light range, so that the living body can be affected without feeling the flicker or glare of white light.
- Violet light is light with a wavelength of 360 to 400 nm, which has a lower visual sensitivity than white light and is in a wavelength range that does not or hardly gives discomfort to living organisms (especially humans).
- light with a wavelength in the range of 350-400 nm such as light with a wavelength of any of 350 nm, 360 nm, 370 nm, 380 nm, 390 nm or 400 nm, or any wavelength defined above Any wavelength of light that falls within the range (eg, 370-390 nm range) may be used.
- the wavelength includes about 380 nm.
- the term "about" used in this specification means to include 5% before and after the numerical value modified by this term.
- the light irradiation state is a constant light (that is, 0 Hz) or a blinking frequency of over 0 Hz to 150 Hz.
- constant (0 Hz) light or flashing frequency light in the range of 30-75 Hz e.g. Light with any flash frequency of 75 Hz, or any flash frequency within the range defined by any of the above flash frequencies (eg, 35-45 Hz range) may be used.
- the blinking frequency is approximately 40 Hz.
- the light can be irradiated with an irradiance of, for example, 0.5 to 1000 ⁇ W/cm 2 .
- an irradiance of, for example, 0.5 to 1000 ⁇ W/cm 2 .
- the control unit controls the irradiation state of the light (including constant light or blinking frequency), irradiance, irradiation time, and the like by transmitting and receiving with an isolation controller such as a mobile terminal. It can be executed by changing irradiation conditions such as irradiation start time, irradiation end time, constant light or flashing frequency.
- the various irradiation conditions described above are controlled in isolation so that irradiation conditions suitable for producing biofunction control can be arbitrarily set to achieve the desired effect. Furthermore, it is possible to measure and evaluate how irradiation of light with a specific wavelength at a flickering frequency or the like affects biological functions, and to what extent the effects on the mind and body are, and apply the results to practical use.
- the light source may be spectacles with a light source (see, for example, FIG. 2), a spectacle frame, a desktop light source, or a light source installed near the face, such as a light source attached to a mobile terminal.
- a light source installed in front of or near the face, such as spectacles with a light source or a spectacle frame that is easy to wear and does not cause discomfort on a daily basis. You can always irradiate even in difficult scenes and environments.
- the light source may be a non-installed light source such as a portable light source, or an installed light source such as a room lighting, table lamp, or dedicated device. Since the biological function control device according to the present invention can induce, for example, an improvement in sleep efficiency or sleep quality, it can be used in the form of a bedside desk light, reading light, desk lighting, wall-mounted lighting, ceiling light, or the like. may be According to some embodiments, the device can have various light source forms depending on the usage environment. For example, the light source may be used in combination with glasses, spectacle lenses, or contact lenses that allow violet light to pass through. Alternatively, sunlight passing through glasses, spectacle lenses, or contact lenses that allow violet light to pass through may be used as a light source.
- the method for controlling biological functions by light stimulation is a method for controlling biological functions by irradiating a living body (for example, mammals including humans) with light of a specific wavelength at a constant light or a specific blinking frequency, It is characterized by controlling the emission of light that controls the function of the living body that receives the light.
- a biological function control device is a device for improving or preventing a biological function by irradiating a living body with constant violet light, comprising: a light source emitting the violet light; and a light emission time control unit that emits light for a specific period.
- the specific time of light irradiation is any time in the range of 10 seconds to 24 hours per day, such as 10 seconds, 30 seconds, 45 seconds, 1 minute, 3 minutes, 5 minutes, 10 minutes, 15 minutes, 30 minutes, 45 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 7 hours, 8 hours, 9 hours, 10 hours, 11 hours, It can be any time of 12 hours, 18 hours, 24 hours, or any time within the range defined by any of the above (eg, 1 to 12 hours).
- the specific period of continued light irradiation is, for example, 1 day, 2 days, 3 days, 4 days, 5 days, 6 days, 1 week, 2 weeks, 3 weeks, 1 month, 2 months, 3 months, 6 months, It can be for a period of 1 year, 2 years, 3 years or more.
- a device and method for promoting increased tear volume a device and method for improving sleep efficiency or sleep quality, a blood glucose level, Reduction or increase suppressing device and method, body temperature reduction promoting device and method, weight gain suppressing device and method, parasympathetic nerve activation promoting device and method, cerebral blood flow and cerebral oxygen concentration increasing promoting device and method, light environment improving device and A method is provided.
- FIG. 10 is a graph showing body temperature of mice illuminated with or without the addition of violet light.
- the bar graph on the left shows the body temperature of 70-week-old mice.
- FIG. 4 is a diagram showing Oxy-Hb variation before and after violet light irradiation (upper) and Oxy-Hb dispersion during violet light irradiation (lower).
- FIG. 3 is a graph showing reduction in blood glucose over a week by violet light irradiation. Changes in glucose mean are shown.
- Fig. 3 is a graph showing reduction in blood glucose over a week by violet light irradiation. Changes in glucose maxima are shown.
- FIG. 4 is a diagram showing the average distribution of cerebral blood flow dynamics; Changes in oxygenated hemoglobin concentration and deoxygenated hemoglobin concentration are shown.
- Figure 18 is a graph quantifying the measurements of Figure 17; Changes in oxygenated hemoglobin concentration, oxygenated hemoglobin concentration, and deoxygenated hemoglobin concentration are shown.
- Apparatus and method for controlling biological functions by light stimulation according to the present invention apparatus and method for promoting increase in tear volume, apparatus and method for improving sleep efficiency or quality of sleep, apparatus and method for suppressing blood glucose level reduction or increase, suppression of weight gain according to the present invention
- a device and method, a device and method for promoting an increase in cerebral blood flow and cerebral oxygen concentration, and a device and method for improving a light environment will be described with reference to the drawings.
- the present invention is not limited to the following embodiments and examples, and includes various modifications and applications within the scope of the present invention.
- a device for controlling biological functions by optical stimulation is a device for controlling biological functions by irradiating a living body with light of a specific wavelength at a constant light or at a specific blinking frequency, wherein the light with the specific wavelength is always lit or It is characterized by comprising a light source that emits light at a specific flickering frequency, and a control unit that controls emission of light that induces control of biological functions of the living body that receives the light.
- This biological function control device can apply various stimuli to the living body by controlling the state of light irradiation. In particular, by influencing a disease or condition related to biological functions, it can be applied to various mental and physical improving effects and therapeutic effects resulting therefrom.
- the control of biological function is control of body temperature, body weight control, blood glucose level control, tear volume control, parasympathetic nerve activation control, sleep efficiency or It relates to, but is not limited to, control of sleep quality, control of cerebral blood flow and cerebral oxygenation.
- irradiation of light in an irradiation state such as a flashing frequency, sound, vibration, magnetic field, electric field, etc. can be applied together, and a combined action of both can be produced.
- the biological function control device is, as described above, a device for controlling a biological function by irradiating a living body with violet light at a constant light or at a specific flickering frequency, wherein the violet light a light source that emits light, a light emission cycle control unit that makes the violet light a constant light or a specific blinking frequency, and a light emission time control unit that irradiates the violet light for a specific time or a specific period, It is characterized in that it is a device used to control the
- the biological function control device is a device for controlling a biological function by irradiating a living body with constant violet light, comprising: a light source emitting the violet light; and a light emission time control unit that irradiates the violet light for a specific time or for a specific period.
- the biological function control device includes at least one light source that emits light and a drive circuit that drives the light source, and the light emitted by the light source is delivered to the living body.
- the present invention relates to a device for controlling biological function by light stimulation, which is light of a specific wavelength that produces a biological function controlling effect by irradiation.
- an apparatus comprises a drive circuit comprising: at least one processor communicatively coupled to the light source and at least one memory; including memory.
- the wavelength of light emitted by the light source is not particularly limited, but violet light defined as 360-400 nm is used in some embodiments.
- a light source whose oscillation frequency can range from 0 (ordinary light, DC light) to 150 Hz can be preferably applied.
- the frequency can be adjusted in units of 0.5 Hz or 1 Hz by setting the control section, and light with any flickering frequency can be generated.
- Increasing the blinking frequency also has the advantage that the blinking becomes less annoying, although there are individual differences.
- the blinking frequency is not limited to 10 Hz or 60 Hz used in the experimental examples.
- the irradiance from the light source may be variable or constant. In some embodiments, but not limited to, a maximum power of 310 ⁇ W/cm 2 is used. For example, in the range of 1 ⁇ W/cm 2 (0.01 W/m 2 ) to 1000 ⁇ W/cm 2 (10 W/m 2 ), or in the range of 0.5 ⁇ W/cm 2 (0.005 W/m 2 ) to 500 ⁇ W/cm 2 (5 W/m 2 ) or 0.5 to 1000 ⁇ W/cm 2 . Furthermore, a light source with such irradiance can be easily applied to spectacles or spectacle frames, or other portable illumination devices, so that they can be worn in daily life. In particular, it has been confirmed that even a very small amount of weak light (light with low photosensitivity) causes a characteristic phenomenon. ) can be expected to be applied.
- the light may be specified by relative luminosity. Since the features of the present invention can be realized even with a low relative luminous efficiency, it is possible to irradiate a blinking violet light that causes stimulation to the living body under the low relative luminous efficiency, and to stimulate a desired part without burdening the living body. can be done.
- the light irradiation time is preferably set arbitrarily according to the purpose, and may be short or long.
- the light can optionally be intermittent (regular or irregular) or continuous.
- the light irradiation time can be set, for example, between 8:00 am and 1:00 pm, between 9:00 am and 12:00 am, or between 10:00 am and 11:00 am. can be at least 10 minutes, at least 15 minutes, at least 20 minutes, at least 30 minutes, at least 1 hour, at least 2 hours, at least 3 hours, at least 4 hours, or 5 hours. In some embodiments, 3 hours of irradiation between 9:00 am and 12:00 am or 2 hours of irradiation between 9:00 am and 11:00 am is applied.
- a timer function can be used for such irradiation with a set time.
- the light source can be spectacles with a light source or a spectacle frame. Such spectacles or spectacle frames are easy to wear and have a light source that emits a blinking frequency attached to the spectacles or spectacle frames that do not cause discomfort on a daily basis.
- the light source may be a light source installed in front of or near the face, such as a desk light source or a light source attached to a mobile terminal, or a non-installed light source such as a portable light source, or an indoor lighting, a desk stand, a dedicated device, or the like.
- the light source may be an installation type light source, and the device may have various light source forms according to the usage environment.
- the control unit is a part that controls the irradiation state of light from the light source (normal light or flashing frequency).
- the controller may include a power source for powering the light source, such power source may be a battery or routed by cable to a battery mounted in another location. good too. Moreover, when it does not move in one place, the form connected to a household power supply etc. may be sufficient.
- the control unit changes the irradiation conditions such as the blinking frequency of the light, the irradiance, the irradiation time, the irradiation start time, the irradiation end time, the blinking frequency, etc. is preferred. Since such a control unit isolates and controls the various irradiation conditions described above, it is possible to arbitrarily set irradiation conditions suitable for producing desired biological function control and obtain desired effects. Furthermore, it is possible to measure and evaluate how irradiation of light with a specific wavelength at the flickering frequency affects biological functions and the extent of the effect on the mind and body, and apply this to practical use.
- control unit may have a light source controller and a timer function.
- the controller can include functions such as changing the frequency and irradiance and setting the irradiation time.
- timer function can be exemplified by one that can set the irradiance time of light. Such a controller and timer function may be provided integrally with the instrument, or may be provided as separate members.
- FIG. 5 shows a simplified block diagram of an example of the device that can be used for the above-described biological function control.
- the device shown in FIG. 5 includes the biological function control device described herein, a tear volume increase promotion device, a sleep efficiency or sleep quality improvement device, a blood glucose level reduction or increase suppression device, and a body temperature reduction promotion device. , weight gain suppression device, parasympathetic nerve activation device, cerebral blood flow and cerebral oxygen concentration increase promotion device, and light environment improvement device (these can be collectively referred to simply as “biological function control device”). , and thus all the devices described herein above can be represented by the block diagram of FIG.
- the biological function control device can have a light source 10 and a controller 20 .
- the light source 10 emits light of a specific wavelength.
- the wavelength of the light emitted by the light source 10 preferably includes VL or 350 to 400 nm, and more preferably includes 380 nm.
- the light source 10 may be any light source, and a light emitting diode (LED) can be preferably used from the viewpoint of small size, long life, and ease of blinking control (an example of the spectrum of a violet fluorescent lamp is shown in FIG. 3, LED (see Figure 4 for an example of the spectrum of ).
- the number of light sources 10 may be one or more depending on the target irradiation intensity and irradiation range of the light sources.
- the control unit 20 is wired or wirelessly connected to the light source 10 and configured to control the irradiation conditions of the light source 10 .
- the irradiation conditions can include at least one of the blinking frequency and the irradiation time of the light source 10, and therefore the control unit 20 can include at least one of the blinking frequency control unit 20a and the irradiation time control unit 20b.
- the blinking frequency may preferably be 0 Hz or 30-75 Hz, more preferably 0 Hz or 35-45 Hz, particularly preferably 0 Hz or 40 Hz.
- the flashing frequency of 0 Hz means a constant light.
- the irradiation time can be arbitrarily determined, for example, in the range of 10 seconds to 24 hours per day, and the specific period of continuation of irradiation can also be arbitrarily determined, for example, from one day to several years or longer. .
- the control unit 20 can include a processor such as a CPU (Central Processing Unit) and executes processing for controlling the irradiation conditions of the light source 10 .
- the processing performed by the control unit 20 may be implemented by a computer program or by hardware based on logic circuits.
- the computer program may be stored on a computer-readable recording medium.
- a recording medium storing a computer program may be a non-transitory recording medium.
- the non-transitory recording medium is not particularly limited, and may be, for example, a memory card, CD-ROM, or other recording medium.
- a computer program stored in a recording medium can be implemented in a computer unit via an appropriate reader. Appropriate readers include, for example, a card reader when the recording medium is a memory card, and a CD drive when the recording medium is a CD-ROM.
- the computer program may be downloaded from an external server to the computer unit via a communication network.
- the biological function control device includes glasses or a glasses frame on which at least the light source 10 out of the light source 10 and the control unit 20 is attached, a desk light, a mobile terminal, a mobile terminal case, head-mounted items (caps, earphones, etc.) headphones, etc.), portable lights, room lights, or lighted products, including table lamps.
- the apparatus for controlling biological functions by optical stimulation can control biological functions by irradiating a living body with light of a specific wavelength such as violet light at a constant light or a specific flickering frequency. .
- a specific wavelength such as violet light at a constant light or a specific flickering frequency.
- it can be applied to various mental and physical improving effects and therapeutic effects resulting therefrom.
- one aspect of the present invention relates to a method for operating a biological function control device using optical stimulation.
- some embodiments of the present invention are a method of operating a device for use in controlling a biological function, the device comprising a light source that irradiates a living body with light of a specific wavelength at constant or a specific flickering frequency. and a controller for controlling the flickering frequency of the light source, wherein the device irradiates a living body with light of a specific wavelength in a normal light or at a specific flickering frequency.
- the blinking frequency of the light source may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm.
- one aspect of the present invention provides a device comprising a light source for irradiating a living body with light of a specific wavelength at a constant light or at a specific blinking frequency, and a controller for controlling the blinking frequency of the light source. It also relates to a computer program for carrying out the method.
- the computer program according to the present invention may be stored in a non-transitory computer-readable medium.
- a computer program according to the present disclosure is capable of performing predetermined steps when instructions are executed by a processor.
- one aspect of the present disclosure is a non-transitory computer-readable medium having instructions stored thereon that, when executed by a processor, emit light of a particular wavelength at all times or at a particular wavelength.
- a device comprising a light source that irradiates a living body with a flickering frequency and a control unit that controls the flickering frequency of the light source, wherein the control unit controls the flickering frequency of the light source in the range of 0 Hz or 30 to 75 Hz. and operating the device such that the light source irradiates a living body with light in the wavelength range of 350-400 nm.
- one aspect of the present invention relates to a method for controlling biological functions by optical stimulation. Therefore, some embodiments of the present invention provide a method of controlling a biological function by irradiating a living body with light of a specific wavelength at a constant light or a specific flickering frequency, wherein the biological function in the living body receiving the light is is controlled. More specifically, some embodiments of the present invention are a method for controlling a biological function in a subject in need of treatment, comprising directing light of a particular wavelength to the subject at steady on or at a particular blinking rate. A method comprising irradiating a living body with a frequency, whereby a biological function is controlled in said living body receiving said light.
- the blinking frequency of the light source used may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm. .
- Tear volume increase promotion device and method The present inventors further investigated the effect of violet light on tear volume. As a result, it was found that the increase in the amount of tear fluid can be promoted or the decrease can be suppressed by light stimulation by irradiation with violet light. Then, based on the knowledge of such effects of light stimulation with violet light, the inventors completed the method and device for promoting increased tear volume according to the present invention.
- the tear volume increase promoting device is a device that irradiates a living body with violet light at a constant light or at a specific flickering frequency to promote an increase in tear volume or suppress a decrease in tear volume.
- a light source that emits the violet light
- a light emission cycle control unit that sets the violet light to a constant light or a specific blinking frequency
- a light emission time control unit that irradiates the violet light for a specific time or a specific period. It is a device used for promoting an increase in the amount of tear fluid or suppressing a decrease in the tear fluid volume.
- the apparatus for promoting tear volume increase is an apparatus for promoting an increase in tear volume by irradiating a living body with normal light of violet light, wherein the violet light emits light. and a light emission time control unit that irradiates the violet light for a specific time or for a specific period.
- the tear volume increase promoting device includes at least one light source that emits light and a drive circuit that drives the light source, and the light emitted by the light source is
- the present invention relates to an apparatus for promoting tear volume increase by photo-stimulation, which is light of a specific wavelength that produces an effect of promoting tear volume increase by irradiating a living body.
- an apparatus according to the present invention comprises a drive circuit comprising: at least one processor communicatively coupled to the light source and at least one memory; including memory.
- one aspect of the present invention relates to a method for operating an apparatus for promoting tear volume increase by optical stimulation.
- some embodiments of the present invention are a method of operating a device for use in promoting tear volume augmentation, wherein the device irradiates a living body with light of a specific wavelength at constant light or at a specific flickering frequency. and a controller for controlling the blinking frequency of the light source, wherein the device irradiates a living body with light of a specific wavelength at a constant light or at a specific blinking frequency.
- the blinking frequency of the light source may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm.
- one aspect of the present invention provides a device comprising a light source for irradiating a living body with light of a specific wavelength at a constant light or at a specific blinking frequency, and a controller for controlling the blinking frequency of the light source. It also relates to a computer program for carrying out the method.
- one aspect of the present invention relates to a method for promoting tear volume increase by light stimulation. Therefore, some embodiments of the present invention provide a method of irradiating a living body with light of a specific wavelength at a constant light or a specific flickering frequency to promote an increase in tear volume, A method characterized in that an increase in tear volume is promoted in More specifically, some embodiments of the present invention are a method for promoting increased tear volume in a subject in need of treatment comprising directing a specific wavelength of light to the subject at constant or A method comprising irradiating a living body with a particular flickering frequency, thereby promoting an increase in tear volume in said living body receiving said light.
- the blinking frequency of the light source used may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm. good.
- a preventive or therapeutic device for corneal diseases configured to irradiate a living body with light of a specific wavelength that produces It also relates to a method of preventing or treating corneal disease comprising the step of More specifically, some embodiments provide a dry eye prophylaxis or treatment device and method of operation configured to irradiate a living body with light of a specific wavelength that produces an effect, or dry eye prophylaxis or treatment.
- the present invention relates to a method for preventing or treating dry eye, including the step of irradiating a living body with light of a specific wavelength that produces a therapeutic effect.
- Such devices or methods may be used in combination with therapeutic agents for dry eye or keratoconjunctival epithelial disorders (sodium hyaluronate, diquafosol sodium, etc.).
- the present inventors further studied the effect of violet light on sleep efficiency or sleep quality. As a result, it was found that light stimulation by irradiation with violet light can improve sleep efficiency or sleep quality. Then, based on the knowledge of such effects of light stimulation with violet light, the inventors completed the method and device for improving sleep efficiency or sleep quality according to the present invention.
- the device for improving sleep efficiency or sleep quality according to the present invention is a device for improving sleep efficiency or sleep quality by irradiating a living body with violet light at a constant light or at a specific flickering frequency.
- a light source that emits the violet light
- a light emission cycle control unit that sets the violet light to a constant light or a specific blinking frequency
- a light emission time control unit that irradiates the violet light for a specific time or a specific period. and is a device used for improving sleep efficiency or quality of sleep.
- the sleep efficiency or sleep quality improvement device is a device for improving sleep efficiency or sleep quality by irradiating a living body with constant violet light, It is characterized by comprising a light source that emits violet light, and a light emission time control section that irradiates the violet light for a specific time or for a specific period.
- the sleep efficiency or sleep quality improvement device also includes at least one light source that emits light, and a driving circuit that drives the light source, and the light source emits The light is light of a specific wavelength that produces an effect of improving sleep efficiency or sleep quality by irradiating the living body.
- an apparatus comprises a drive circuit comprising: at least one processor communicatively coupled to the light source and at least one memory; including memory.
- one aspect of the present invention relates to a method of operating a device for improving sleep efficiency or sleep quality by light stimulation. Accordingly, some embodiments of the present invention are methods of operating a device for use in improving sleep efficiency or quality, wherein the device emits light of a specific wavelength to the body at a constant or a specific flickering frequency. and a controller for controlling the blinking frequency of the light source, wherein the device irradiates a living body with light of a specific wavelength at a constant light or at a specific blinking frequency.
- the blinking frequency of the light source may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm.
- one aspect of the present invention provides a device comprising a light source for irradiating a living body with light of a specific wavelength at a constant light or at a specific blinking frequency, and a controller for controlling the blinking frequency of the light source. It also relates to a computer program for carrying out the method.
- one aspect of the present invention relates to a method for improving sleep efficiency or sleep quality by light stimulation. Therefore, some embodiments of the present invention provide a method for improving sleep efficiency or sleep quality by irradiating a living body with light of a specific wavelength at a constant light or a specific flickering frequency, A method characterized in that sleep efficiency or sleep quality is improved in vivo. More specifically, some embodiments of the present invention provide a method for improving sleep efficiency or sleep quality in a subject in need of treatment comprising exposing the subject to constant light of a particular wavelength. or irradiating a living body with a particular flickering frequency, whereby sleep efficiency or sleep quality is improved in said living body receiving said light.
- the blinking frequency of the light source used may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm. good.
- one aspect of the present invention is to produce an effect of preventing or treating sleep disorders and related diseases.
- Devices for preventing or treating sleep disorders and diseases related thereto configured to irradiate a living body with light of specific wavelengths, and operating methods thereof, or lights of specific wavelengths that produce preventive or therapeutic effects for sleep disorders and diseases related thereto It also relates to a method for preventing or treating sleep disorders and related diseases, including the step of irradiating the living body with More specifically, some embodiments are a sleep disorder preventive or therapeutic device configured to irradiate a living body with light of a specific wavelength that produces a sleep disorder preventive or therapeutic effect, and a method of operating the same.
- the present invention relates to a method for preventing or treating sleep disorders, which includes the step of irradiating a living body with light of a specific wavelength that produces sleep disorder preventive or therapeutic effects.
- sleep disorders Such devices or methods may be used in combination with hypnotics (benzodiazepines, brotizolam, estazolam, quazepam, etc.).
- some embodiments are directed to a device for eliminating jet lag configured to irradiate a living body with light of a specific wavelength that produces an effect of eliminating jet lag such as jet lag, and a method of operating the same, or an effect of eliminating jet lag.
- It relates to a method for eliminating jet lag, which includes the step of irradiating a living body with light of a specific wavelength that causes
- some embodiments are configured to irradiate the living body with light of a specific wavelength that produces a sleep-inducing effect, such as a night shift, which allows people who work at night to fall asleep earlier.
- the present invention relates to an inducing device and its operating method, or to a sleep inducing method including the step of irradiating a living body with light of a specific wavelength that produces a sleep inducing effect.
- some embodiments also include a drowsiness suppressor configured to irradiate a living body with light of a specific wavelength that produces a drowsiness suppressing effect that prevents a person working at night, such as a night shift, from falling asleep. It also relates to a device and a method of operating the same, or a drowsiness-suppressing method comprising irradiating a living body with light of a specific wavelength that produces a drowsiness-suppressing effect.
- the blood glucose level reduction or increase suppression device is a device for reducing or increasing blood glucose level by irradiating a living body with violet light at a constant light or at a specific flickering frequency.
- a light source that emits the violet light
- a light emission cycle control unit that makes the violet light a constant light or a specific blinking frequency
- a light emission time control unit that irradiates the violet light for a specific time or for a specific period.
- the blood glucose level reduction or increase suppression device is a device for reducing or increasing the blood glucose level by irradiating a living body with constant violet light. and a light source for emitting the violet light, and a light emission time control section for emitting the violet light for a specific time or for a specific period.
- the blood glucose level reduction or increase suppression device includes at least one light source that emits light and a drive circuit that drives the light source, and the light source is The emitted light is light of a specific wavelength that produces an effect of reducing or increasing the blood glucose concentration by irradiating the living body.
- an apparatus comprises a drive circuit comprising: at least one processor communicatively coupled to the light source and at least one memory; including memory.
- one aspect of the present invention relates to a method of operating a device for reducing or increasing blood glucose concentration by light stimulation. Accordingly, some embodiments of the present invention are methods of operating a device for use in improving sleep efficiency or quality, wherein the device emits light of a specific wavelength to the body at a constant or a specific flickering frequency. and a controller for controlling the blinking frequency of the light source, wherein the device irradiates a living body with light of a specific wavelength at a constant light or at a specific blinking frequency.
- the blinking frequency of the light source may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm.
- one aspect of the present invention provides a device comprising a light source for irradiating a living body with light of a specific wavelength at a constant light or at a specific blinking frequency, and a controller for controlling the blinking frequency of the light source. It also relates to a computer program for carrying out the method.
- one aspect of the present invention relates to a method for reducing or suppressing an increase in blood glucose concentration by light stimulation. Therefore, some embodiments of the present invention provide a method for reducing or suppressing an increase in blood glucose level by irradiating a living body with light of a specific wavelength at a constant light or a specific flickering frequency, wherein It relates to a method, characterized in that the blood glucose level is reduced or inhibited from increasing in said living body. More specifically, some embodiments of the present invention are methods for reducing or inhibiting increases in blood glucose levels in a subject in need of treatment, comprising constantly exposing the subject to a specific wavelength of light.
- a method comprising irradiating a living body with a light or a particular flickering frequency, whereby blood glucose levels are reduced or increased in said living body receiving said light.
- the blinking frequency of the light source used may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm. good.
- one aspect of the present invention is a diabetes preventive that is configured to irradiate a living body with light of a specific wavelength that produces the preventive effect of diabetes.
- the present invention also relates to a device and method of operation thereof, or a method of preventing diabetes comprising the step of irradiating a living body with light of a specific wavelength that produces a preventive effect against diabetes.
- some embodiments are a diabetes prevention device configured to irradiate a living body with light of a specific wavelength that produces a diabetes prevention effect and a method of operating the same, or a specific wavelength that produces a diabetes prevention effect It relates to a diabetes prevention method including the step of irradiating a living body with light of Such devices or methods may be used in combination with blood sugar lowering drugs (insulin, pigguanides, sulfonylureas, thiazolidines, DPP-4 inhibitors, etc.) or foods (supplements). Furthermore, some embodiments are configured to irradiate a living body with light of a specific wavelength that produces a preventive effect for chronic renal disorder, arteriosclerosis, cerebral infarction, and gout.
- blood sugar lowering drugs insulin, pigguanides, sulfonylureas, thiazolidines, DPP-4 inhibitors, etc.
- foods supplements
- some embodiments are configured to irradiate a living body with light
- Gout preventive device and its operation method or chronic renal disorder, arteriosclerosis, cerebral infarction, chronic renal disorder, arteriosclerosis, cerebral infarction, gout including the step of irradiating a living body with light of a specific wavelength that produces a preventive effect for chronic renal disorder, arteriosclerosis, cerebral infarction, gout concerning the preventive method of
- Such devices or methods include statins (HMG-CoA reductase inhibitors), fibrates, nicotinic acid derivatives, probucol, ethyl icosapentate (EPA), febuxostat, allopurinol, angiotensin converting enzyme inhibitors, angiotensin receptors. It may be used in combination with drugs such as body antagonists, diuretics, steroids, and the like.
- the present inventors further conducted research on the effect of violet light on body temperature. As a result, it was found that the photo-stimulation caused by the irradiation of violet light could accelerate the decrease in body temperature. Then, based on the knowledge of such effects of light stimulation by violet light, the inventors have completed the method and apparatus for promoting a decrease in body temperature according to the present invention.
- the device for promoting body temperature reduction according to the present invention is a device for promoting body temperature reduction by irradiating a living body with violet light at a constant light or at a specific flickering frequency, wherein the violet light is emitted.
- the device for promoting body temperature reduction according to the present invention is a device for promoting body temperature reduction by irradiating a living body with normal violet light, comprising: a light source emitting the violet light; and a light emission time control unit that irradiates the violet light for a specific time or for a specific period.
- the device for promoting body temperature reduction according to the present invention includes at least one light source that emits light and a drive circuit that drives the light source, and the light emitted by the light source is delivered to the living body.
- the present invention relates to a device for promoting body temperature reduction by photo-stimulation, which is light of a specific wavelength that produces an effect of promoting body temperature reduction by irradiation.
- an apparatus according to the present invention comprises a drive circuit comprising: at least one processor communicatively coupled to the light source and at least one memory; including memory.
- one aspect of the present invention relates to a method for operating a device for promoting body temperature reduction by optical stimulation.
- some embodiments of the present invention are a method of operating a device for use in promoting hypothermia, wherein the device comprises a light source that irradiates a living body with light of a specific wavelength at constant light or at a specific flickering frequency. and a controller for controlling the flickering frequency of the light source, wherein the device irradiates a living body with light of a specific wavelength in a normal light or at a specific flickering frequency.
- the blinking frequency of the light source may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm.
- one aspect of the present invention provides a device comprising a light source for irradiating a living body with light of a specific wavelength at a constant light or at a specific blinking frequency, and a controller for controlling the blinking frequency of the light source. It also relates to a computer program for carrying out the method.
- one aspect of the present invention relates to a method for promoting a decrease in body temperature by light stimulation. Therefore, some embodiments of the present invention provide a method of irradiating a living body with light of a specific wavelength at a constant light or a specific flickering frequency to accelerate body temperature reduction, is promoted. More specifically, some embodiments of the present invention provide a method for promoting hypothermia in a subject in need of treatment comprising directing a constant or a particular blinking light of a particular wavelength to the subject. A method comprising irradiating a living body with a frequency, whereby hypothermia is promoted in said living body receiving said light.
- the blinking frequency of the light source used may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm. good.
- one aspect of the present invention is to irradiate a living body with light of a specific wavelength that produces a preventive effect on aging-related diseases.
- the present invention also relates to an aging-related disease preventive device configured as described above and an operation method thereof, or an aging-related disease preventive method including a step of irradiating a living body with light of a specific wavelength that produces an aging-related disease preventive effect.
- some embodiments are directed to an anti-obesity device configured to irradiate a living body with light of a specific wavelength that produces an anti-obesity effect and a method of operating the same, or a specific wavelength that produces an anti-obesity effect It relates to a method for preventing obesity, which includes the step of irradiating a living body with light of Such devices or methods may be used in combination with anti-obesity drugs (Mazindol, Orlistat, etc.) or diet foods (supplements).
- the weight gain suppression device is a device for suppressing weight gain by irradiating a living body with violet light at a constant light or at a specific flickering frequency, wherein the violet light emits light.
- the weight gain suppression device is a device that irradiates a living body with constant violet light to promote weight gain suppression, comprising: a light source that emits the violet light; and a light emission time control unit that irradiates the violet light for a specific time or for a specific period.
- the weight gain suppressing device includes at least one light source that emits light and a drive circuit that drives the light source, and the light emitted by the light source is delivered to the living body.
- the present invention relates to a device for suppressing weight gain using photostimulation, which is light of a specific wavelength that produces a weight gain suppressing effect when irradiated.
- an apparatus comprises a drive circuit comprising: at least one processor communicatively coupled to the light source and at least one memory; including memory.
- one aspect of the present invention relates to a method for operating a weight gain suppressing device using optical stimulation.
- some embodiments of the present invention are a method of operating a device for use in reducing weight gain, wherein the device comprises a light source that irradiates a living body with light of a specific wavelength at constant light or at a specific flickering frequency. and a controller for controlling the flickering frequency of the light source, wherein the device irradiates a living body with light of a specific wavelength in a normal light or at a specific flickering frequency.
- the blinking frequency of the light source may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm.
- one aspect of the present invention provides a device comprising a light source for irradiating a living body with light of a specific wavelength at a constant light or at a specific blinking frequency, and a controller for controlling the blinking frequency of the light source. It also relates to a computer program for carrying out the method.
- one aspect of the present invention relates to a method for suppressing weight gain by light stimulation. Therefore, some embodiments of the present invention provide a method of irradiating a living body with light of a specific wavelength at a constant light or a specific flickering frequency to promote suppression of weight gain, wherein the body that receives the light loses weight. It relates to a method, characterized in that the suppression of growth is facilitated. More specifically, some embodiments of the present invention provide a method for promoting weight reduction in a subject in need of treatment, comprising exposing the subject to constant or specific wavelengths of light. A method comprising irradiating a living body with a flickering frequency, thereby promoting suppression of weight gain in said living body receiving said light.
- the blinking frequency of the light source used may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm. good.
- one aspect of the present invention is a specific
- the present invention also relates to a metabolic activation device configured to irradiate a living body with light of a wavelength and a method of operating the same, or a metabolic activation method including a step of irradiating a living body with light of a specific wavelength that produces a metabolic activation effect.
- a fat burning promoting device configured to irradiate a living body with light of a specific wavelength that produces a fat burning promoting effect and an operating method thereof, or a fat burning promoting effect is produced.
- the present invention relates to a method for promoting fat burning, including the step of irradiating a living body with light of a specific wavelength.
- a mitochondrial activation device configured to irradiate a living body with light of a specific wavelength that produces a mitochondrial activation effect, and a method of operating the same, or a mitochondrial activation effect. It also relates to a method for activating mitochondria, which includes the step of irradiating a living body with light of a specific wavelength.
- the parasympathetic nerve activation promoting device is a device for promoting the activation of the parasympathetic nerve by irradiating a living body with violet light at constant light or at a specific flickering frequency, A light source that emits violet light, a light emission cycle control unit that makes the violet light a constant light or a specific blinking frequency, and a light emission time control unit that irradiates the violet light for a specific time or a specific period, and is parasympathetic.
- the device is characterized by being a device used to promote activation of nerves.
- the parasympathetic nerve activation device is a device for irradiating a living body with constant light of violet light to promote activation of the parasympathetic nerve, wherein the violet light is emitted. It is characterized by comprising a light source and a light emission time control section for irradiating the violet light for a specific time or for a specific period.
- the parasympathetic nerve activation device includes at least one light source that emits light, and a drive circuit that drives the light source.
- the present invention relates to a device for activating a parasympathetic nerve by light stimulation, which is light of a specific wavelength that causes a parasympathetic nerve activation effect by irradiating the device.
- an apparatus comprises a drive circuit comprising: at least one processor communicatively coupled to the light source and at least one memory; including memory.
- one aspect of the present invention relates to a method for operating a device for promoting parasympathetic nerve activation by optical stimulation. Accordingly, some embodiments of the present invention are a method of operating a device for use in promoting parasympathetic activation, wherein the device irradiates a living body with light of a specific wavelength at constant light or at a specific flickering frequency. and a controller for controlling the blinking frequency of the light source, wherein the device irradiates a living body with light of a specific wavelength at a constant light or at a specific blinking frequency.
- the blinking frequency of the light source may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm.
- one aspect of the present invention provides a device comprising a light source for irradiating a living body with light of a specific wavelength at a constant light or at a specific blinking frequency, and a controller for controlling the blinking frequency of the light source. It also relates to a computer program for carrying out the method.
- one aspect of the present invention relates to a method for promoting parasympathetic nerve activation by light stimulation. Therefore, some embodiments of the present invention provide a method for promoting parasympathetic nerve activation by irradiating a living body with light of a specific wavelength at a constant light or a specific flickering frequency, comprising: The present invention relates to a method, characterized in that parasympathetic nerve activation is promoted. More specifically, some embodiments of the present invention provide a method for promoting parasympathetic activation in a subject in need of treatment, comprising directing a constant or specific wavelength of light to the subject.
- the blinking frequency of the light source used may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm. good.
- one aspect of the present invention is to produce an effect of reducing stress or fatigue in a living body.
- a stress or fatigue reduction device configured to irradiate a living body with light of a specific wavelength and its operation method, or a stress including a step of irradiating a living body with light of a specific wavelength that produces a stress or fatigue reduction effect Or it also relates to a method for reducing fatigue.
- some embodiments are a constipation relieving device configured to irradiate a living body with light of a specific wavelength that produces constipation relieving effects, and an operating method thereof, or light of a specific wavelength that produces constipation relieving effects.
- the present invention relates to a method for relieving constipation, including the step of irradiating a living body.
- Such devices or methods may be used in combination with laxatives.
- the apparatus for promoting an increase in cerebral blood flow and cerebral oxygen concentration irradiates a living body with violet light at a constant light or at a specific flickering frequency to increase cerebral blood flow and cerebral oxygen concentration.
- a light source that emits the violet light
- a light emission cycle control unit that makes the violet light a constant light or a specific flickering frequency
- a controller and is a device used to promote an increase in cerebral blood flow and cerebral oxygen concentration.
- the device for promoting cerebral blood flow and cerebral oxygen concentration increase is a device that promotes an increase in cerebral blood flow and cerebral oxygen concentration by irradiating a living body with normal violet light. and a light source that emits the violet light, and a light emission time control unit that irradiates the violet light for a specific time or for a specific period.
- the device for promoting cerebral blood flow and cerebral oxygen concentration increase includes at least one light source that emits light and a drive circuit that drives the light source, and the light source is The emitted light is light of a specific wavelength that promotes an increase in cerebral blood flow and cerebral oxygen concentration by irradiating the living body.
- an apparatus according to the present invention comprises a drive circuit comprising: at least one processor communicatively coupled to the light source and at least one memory; including memory.
- one aspect of the present invention relates to a method for operating a device for promoting cerebral blood flow and cerebral oxygen concentration increase by optical stimulation. Accordingly, some embodiments of the present invention are methods of operating a device for use in promoting increased cerebral blood flow and cerebral oxygenation, wherein the device emits light of a specific wavelength at constant or at a specific flicker frequency. and a controller for controlling the flickering frequency of the light source, wherein the device irradiates the living body with light of a specific wavelength at a constant light or at a specific flickering frequency.
- the blinking frequency of the light source may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm.
- one aspect of the present invention provides a device comprising a light source for irradiating a living body with light of a specific wavelength at a constant light or at a specific blinking frequency, and a controller for controlling the blinking frequency of the light source. It also relates to a computer program for carrying out the method.
- one aspect of the present invention relates to a method for promoting an increase in cerebral blood flow and cerebral oxygen concentration by light stimulation. Therefore, some embodiments of the present invention provide a method for promoting cerebral blood flow and cerebral oxygen concentration increase by irradiating a living body with light of a specific wavelength at a constant light or a specific flickering frequency, comprising: and cerebral blood flow and increased cerebral oxygen concentration are promoted in said living body. More specifically, some embodiments of the present invention are a method for promoting cerebral blood flow and cerebral oxygenation in a subject in need of treatment comprising directing light of a particular wavelength to the subject.
- a method comprising irradiating a living body with constant light or a specific flickering frequency, thereby promoting cerebral blood flow and increased cerebral oxygen concentration in said living body receiving said light.
- the blinking frequency of the light source used may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm. good.
- the light environment improvement device can be used in a living environment even in an environment where it is not possible to take sufficient sunlight or exercise a moderate amount due to continuous remote work at home, for example. It is possible to improve the indoor work environment by having a favorable influence on sleep, blood sugar level, and cerebral blood flow.
- the optical environment improving device is a device for controlling biological functions by irradiating a living body with violet light at a constant light or at a specific flickering frequency, comprising: a light source emitting the violet light; a constant light or a specific flickering frequency, and a light emission time control unit that irradiates the violet light for a specific time or for a specific period, and is used to improve control of biological functions.
- the control of biological function is control of body temperature, body temperature control, body weight control, blood glucose level control, tear volume control, parasympathetic nerve activation control , control of sleep efficiency or quality, control of cerebral blood flow and cerebral oxygenation, but are not limited thereto.
- the light source may be used in combination with glasses, spectacle lenses, or contact lenses that allow violet light to pass through.
- sunglasses, spectacle lenses, or contact lenses that allow violet light to pass through may be used as a light source.
- spectacles or contact lenses using glass that allows violet light to pass through have a higher biological function control effect than spectacles or contact lenses using normal lenses.
- the optical environment improving device is a device for controlling a biological function by irradiating a living body with normal violet light, comprising: a light source emitting the violet light; and a light emission time control unit that irradiates the violet light for a specific time or for a specific period.
- the optical environment improving device includes at least one light source that emits light and a driving circuit that drives the light source, and the light emitted by the light source is delivered to the living body.
- the present invention relates to a device for improving a light environment by light stimulation, which is light of a specific wavelength that produces a biological function control effect when irradiated.
- an apparatus according to the present invention comprises a drive circuit comprising: at least one processor communicatively coupled to the light source and at least one memory; including memory.
- one aspect of the present invention relates to a method of operating a device for improving the optical environment by optical stimulation.
- some embodiments of the present invention are a method of operating a device for use in improving the lighting environment, wherein the device comprises a light source that irradiates a living body with light of a specific wavelength at constant light or at a specific flickering frequency. and a control unit for controlling the flickering frequency of the light source, wherein the device irradiates a living body with light of a specific wavelength in a normal light or at a specific flickering frequency.
- the blinking frequency of the light source may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm.
- one aspect of the present invention provides a device comprising a light source for irradiating a living body with light of a specific wavelength at a constant light or at a specific blinking frequency, and a controller for controlling the blinking frequency of the light source. It also relates to a computer program for carrying out the method.
- one aspect of the present invention relates to a method for improving the light environment by light stimulation. Therefore, some embodiments of the present invention provide a method of irradiating a living body with light of a specific wavelength at a constant light or a specific flickering frequency in order to improve an indoor environment, A method, characterized in that a biological function is controlled in a living organism. More specifically, some embodiments of the present invention are a method for controlling bodily functions in a subject in need of treatment to improve the indoor environment, comprising: It relates to a method comprising the step of irradiating a living body with light at constant light or at a specific flickering frequency, whereby a biological function is controlled in said living body receiving said light.
- the blinking frequency of the light source used may be controlled in the range of 0 Hz or 30 to 75 Hz, and the light source may irradiate the living body with light having a wavelength in the range of 350 to 400 nm. good.
- one aspect of the present invention relates to a device for improving the light environment by light stimulation, and the device may include glasses, spectacle lenses, or contact lenses that allow violet light to pass through.
- the use of such devices can positively affect bodily functions.
- the control of biological functions that can be achieved by using such devices includes the control of body temperature, body temperature control, body weight control, blood glucose concentration control, tear volume control, and parasympathetic nerve activation control. including, but not limited to, control, control of sleep efficiency or quality, control of cerebral blood flow and cerebral oxygenation.
- Control of other biological functions includes the prevention or treatment of corneal diseases, the prevention or treatment of dry eye, the prevention or treatment of sleep disorders and related diseases, the prevention or treatment of sleep disorders, the elimination of jet lag, the induction of sleep, and drowsiness.
- violet light is also expressed as "VL”.
- Violet light used light with a wavelength of 360 to 400 nm, and flashing irradiation was performed within the irradiance range of 0.5 to 1000 ⁇ W/cm 2 .
- Fig. 13 is a graph showing changes in body temperature from 8 hours before falling asleep. Mean body temperature change (X-axis) and body temperature (Y-axis) for eight subjects are shown. It is considered important for body temperature to drop steadily at sleep onset, indicating that sleep onset is promoted by VL. While Table 2 above is sleep quality data, this one focuses on promoting sleep onset.
- FIG. 14 is a graph showing changes in body temperature before and after sleep and during wakefulness. They often use PCs and smartphones before going to bed, and their body temperature is often uneven before and after sleep, and such a phenomenon was observed in the control (without VL). With the intervention of VL irradiation, the body temperature stabilizes before sleep and gradually decreases at sleep onset. This suggests that the circadian cycle is in order and sleep onset is promoted.
- Figures 15 and 16 show the decrease in blood glucose over a week due to violet light irradiation. It was shown in an experiment with a woman in her 40s that daily blood glucose could be controlled by violet irradiation for 3 hours every day. It is understood that the effect can be obtained regardless of age, such as middle-aged people as well as young people.
- the above results show that the blood glucose concentration can be reduced or suppressed from increasing by irradiating a living body with light of a specific wavelength using a device that irradiates a living body with light of a specific wavelength.
- mice Genetically engineered hypothermic mice, calorie-restricted mice, and growth hormone GH-deficient mice are known to have extended lifespans and increased metabolic activity, such as high oxygen consumption relative to body weight (Conti et al. , Science 03 Nov 2006: Vol. 314, Issue 5800, pp. 825-828, DOI: 10.1126/science.1132191; Bartke & Westbrook, Front. Genet., 13 December 2012, https://doi.org/10.3389/ fgene.2012.00288). Violet light stimulation is thought to be able to control weight loss by activating metabolism.
- weight gain can be suppressed by irradiating a living body with light of a specific wavelength using a device that irradiates a living body with light of a specific wavelength.
- a high value indicates sympathetic nerve dominance, and a low value indicates parasympathetic nerve dominance.
- violet light irradiation reduces the LH/HF ratio, suggesting parasympathetic nerve dominance. From these results, it is understood that irradiation with violet light makes the parasympathetic nervous system dominant, and that relaxation effects, promotion of insulin secretion, and promotion of blood flow can be obtained.
- the above results show that the activation of the parasympathetic nerve can be promoted by irradiating a living body with light of a specific wavelength using a device that irradiates a living body with light of a specific wavelength.
- Fig. 17 shows the average distribution of cerebral hemodynamics, showing a trend of increased deoxygenated hemoglobin in the frontal region. Oxygen consumption is increased in the right hemisphere, suggesting that this technology could be applied to promote creativity, art, and flexibility, and to treat moyamoya disease, apraxia, and agnosia.
- Fig. 18 supplements the results of Fig. 17 by quantifying the entire frontal lobe. A trend toward decreased oxygenated hemoglobin and increased deoxygenated hemoglobin in the forehead was observed. The numerical values are summarized in Table 6 below.
- the above results show that the sleep efficiency or sleep quality of a living body can be improved by irradiating a living body with light of a specific wavelength using a device that irradiates a living body with light of a specific wavelength.
- (Appendix 1) Light comprising at least one light source that emits light and a drive circuit that drives the light source, wherein the light emitted by the light source is light of a specific wavelength that produces a biological function control effect when applied to a living body.
- a biological function control device using stimulation. It has at least one light source that emits light and a drive circuit that drives the light source, and the light emitted by the light source is light of a specific wavelength that, when irradiated to a living body, produces an effect of promoting an increase in the amount of tear fluid. , A device that promotes increased tear volume by light stimulation.
- At least one light source that emits light, and a drive circuit that drives the light source, and the light emitted by the light source has a specific wavelength that improves sleep efficiency or sleep quality when irradiated to a living body.
- a device for improving sleep efficiency or sleep quality by light stimulation. At least one light source that emits light, and a drive circuit that drives the light source, and the light emitted by the light source has a specific wavelength that causes an effect of reducing or suppressing an increase in blood glucose concentration by irradiating a living body.
- a light-stimulated blood glucose level reduction or increase inhibitory device is a specific wavelength that causes an effect of reducing or suppressing an increase in blood glucose concentration by irradiating a living body.
- (Appendix 5) Light comprising at least one light source that emits light and a drive circuit that drives the light source, wherein the light emitted by the light source is light of a specific wavelength that causes a body temperature lowering effect when irradiated to a living body.
- a device that promotes hypothermia through stimulation. At least one light source that emits light, and a drive circuit that drives the light source, wherein the light emitted by the light source is light of a specific wavelength that produces an effect of suppressing weight gain when applied to a living body.
- a device for suppressing weight gain by stimulation At least one light source that emits light, and a drive circuit that drives the light source, wherein the light emitted by the light source is light of a specific wavelength that produces an effect of suppressing weight gain when applied to a living body.
- Device for promoting parasympathetic nerve activation by light stimulation. At least one light source that emits light, and a drive circuit that drives the light source, wherein the light emitted by the light source has a specific wavelength that promotes an increase in cerebral blood flow and cerebral oxygen concentration when applied to a living body.
- a device for promoting cerebral blood flow and cerebral oxygen concentration increase by optical stimulation.
- (Appendix 9) Light comprising at least one light source that emits light and a drive circuit that drives the light source, wherein the light emitted by the light source is light of a specific wavelength that produces a biological function control effect when applied to a living body.
- Light environment improvement device by stimulation (Appendix 10) 10. The device according to any one of the clauses 1-9, wherein the light is violet light.
- (Appendix 11) 11. The device according to any one of clauses 1-10, wherein said specific wavelength comprises 350-400 nm. (Appendix 12) 12. The apparatus of Clause 11, wherein the specific wavelength comprises approximately 380 nm. (Appendix 13) 13.
- control unit controls the blinking frequency of the light source in the range of 0 Hz or 30 to 75 Hz, and the light source irradiates the living body with light having a wavelength in the range of 350 to 400 nm. including, how it works.
- Appendix 19 19. The method of operation of claim 18, wherein said specific wavelength is approximately 380 nm.
- Appendix 20 20. The method of operation according to clause 18 or 19, wherein said particular blinking frequency is 0 Hz or about 40 Hz.
- 21. A method of operation according to any one of claims 20.
- (Appendix 24) Irradiate the living body with a violet light at a constant light or a specific blinking frequency, a) for the prevention or treatment of corneal diseases, b) for preventing or treating dry eye, c) for the prevention or treatment of sleep disorders and related diseases; d) to prevent or treat sleep disorders, e) to combat jet lag, f) to induce sleep, g) to suppress drowsiness, h) to prevent diabetes, i) to prevent chronic kidney damage, arteriosclerosis, cerebral infarction, or gout, j) to prevent obesity, k) for preventing aging-related diseases, l) to activate the metabolism, m) to promote fat burning, n) to promote mitochondrial activation, o) to relieve stress or fatigue, or p) to relieve constipation,
- a device comprising: a light source that emits the violet light; a light emission cycle control unit that makes the violet light a constant light or a specific blinking frequency; and a light emission time control unit that
- (Appendix 25) Irradiate the living body with the constant light of the violet light, a) prevent or treat corneal diseases, b) prevent or treat dry eye, c) prevent or treat sleep disorders and related diseases; d) prevent or treat sleep disorders; e) relieve jet lag, f) induce sleep, g) suppress drowsiness, h) prevent diabetes, i) prevent chronic kidney damage, arteriosclerosis, stroke, or gout; j) prevent obesity, k) prevent aging-related diseases, l) activate metabolism, m) promote fat burning, n) promotes mitochondrial activation; o) reduce stress or fatigue, or p) relieve constipation,
- a device comprising: a light source that emits the violet light; and a light emission time controller that irradiates the violet light for a specific time or for a specific period.
- (Appendix 27) a) prevent or treat corneal diseases, b) prevent or treat dry eye, c) prevent or treat sleep disorders and related diseases; d) prevent or treat sleep disorders; e) relieve jet lag, f) induce sleep, g) suppress drowsiness, h) prevent diabetes, i) prevent chronic kidney damage, arteriosclerosis, stroke, or gout; j) prevent obesity, k) prevent aging-related diseases, l) activate metabolism, m) promote fat burning, n) promotes mitochondrial activation; o) reduce stress or fatigue, or p) relieve constipation, A method of operating a device for use in a method for , the control unit controlling the blinking frequency of the light source in the range of 0 Hz or 30 to 75 Hz; and the light source irradiating the living body with light having a wavelength in the range of 350 to 400 nm.
- Appendix 28 A computer program for causing an apparatus comprising a light source for irradiating a living body with light of a specific wavelength at a constant light or at a specific blinking frequency and a controller for controlling the blinking frequency of the light source to execute the operation method of appendix 26.
- (Appendix 32) In a subject in need of treatment, a) prevent or treat corneal diseases, b) prevent or treat dry eye, c) prevent or treat sleep disorders and related diseases; d) prevent or treat sleep disorders; e) relieve jet lag, f) induce sleep, g) suppress drowsiness, h) prevent diabetes, i) prevent chronic kidney damage, arteriosclerosis, stroke, or gout; j) prevent obesity, k) prevent aging-related diseases, l) activate metabolism, m) promote fat burning, n) promotes mitochondrial activation; o) reduce stress or fatigue, or p) relieve constipation, comprising glasses, spectacle lenses or contact lenses that allow violet light to pass through.
- (Appendix 33) A method for producing a biofunction-regulating effect in a subject in need of treatment, the method comprising irradiating the subject with light of a particular wavelength. (Appendix 34) 10. Any of Clauses 1-9, wherein the drive circuitry includes at least one processor communicatively connected to a light source and at least one memory, and at least one memory for storing processor-executable instructions. A device according to claim 1.
- (Appendix 35) at least one light source that emits light; a driving circuit for driving the light source; has the drive circuitry includes at least one processor communicatively connected to a light source and at least one memory; and at least one memory for storing processor-executable instructions;
- the light source is configured to emit light of a specific wavelength that produces a biological function control effect by irradiating the living body. Biofunction control device by optical stimulation.
Abstract
Description
本発明に係る光刺激による生体機能制御装置は、特定波長の光を常灯又は特定の点滅周波数で生体に照射して生体機能制御を行う装置であって、前記特定波長の光を常灯又は特定の点滅周波数で照射する光源と、前記光を受けた前記生体の生体機能制御を誘導する光を発光制御する制御部とを有する、ことを特徴とする。 [Biological function control device by optical stimulation]
A device for controlling biological functions by optical stimulation according to the present invention is a device for controlling biological functions by irradiating a living body with light of a specific wavelength at a constant light or at a specific blinking frequency, wherein the light with the specific wavelength is always lit or It is characterized by comprising a light source that emits light at a specific flickering frequency, and a control unit that controls emission of light that induces control of biological functions of the living body that receives the light.
光源が発光する光の波長は特に限定されないが、一部の実施形態では360~400nmで定義されるバイオレットライトが使用される。 (light source)
The wavelength of light emitted by the light source is not particularly limited, but violet light defined as 360-400 nm is used in some embodiments.
制御部は、光源からの光の照射状態(常灯や点滅周波数)をコントロールする部分である。制御部は、光源に電力を供給するための電源を備えたものであってもよく、そうした電源はバッテリーであってもよいし、別の位置に装着したバッテリーまでケーブルで引き回したものであってもよい。また、一箇所で動かない場合には、家庭用電源等に接続する形態であってもよい。 (control part)
The control unit is a part that controls the irradiation state of light from the light source (normal light or flashing frequency). The controller may include a power source for powering the light source, such power source may be a battery or routed by cable to a battery mounted in another location. good too. Moreover, when it does not move in one place, the form connected to a household power supply etc. may be sufficient.
本発明者らは、さらにバイオレットライトによる涙液量への影響についての研究を行った。その結果、バイオレットライトの照射による光刺激により、涙液量の増加を促進、又は低減を抑制できることがわかった。そして、バイオレットライトによる光刺激でのこうした効果の知見に基づき、本発明に係る涙液量増加促進方法及び装置を完成するに至った。 [Tear volume increase promotion device and method]
The present inventors further investigated the effect of violet light on tear volume. As a result, it was found that the increase in the amount of tear fluid can be promoted or the decrease can be suppressed by light stimulation by irradiation with violet light. Then, based on the knowledge of such effects of light stimulation with violet light, the inventors completed the method and device for promoting increased tear volume according to the present invention.
本発明者らは、さらにバイオレットライトによる睡眠効率又は睡眠の質への影響についての研究を行った。その結果、バイオレットライトの照射による光刺激により、睡眠効率又は睡眠の質を改善できることがわかった。そして、バイオレットライトによる光刺激でのこうした効果の知見に基づき、本発明に係る睡眠効率又は睡眠の質の改善方法及び装置を完成するに至った。 [Device and method for improving sleep efficiency or sleep quality]
The present inventors further studied the effect of violet light on sleep efficiency or sleep quality. As a result, it was found that light stimulation by irradiation with violet light can improve sleep efficiency or sleep quality. Then, based on the knowledge of such effects of light stimulation with violet light, the inventors completed the method and device for improving sleep efficiency or sleep quality according to the present invention.
本発明者らは、さらにバイオレットライトによる血中グルコース濃度への影響についての研究を行った。その結果、バイオレットライトの照射による光刺激により、血中グルコース濃度を低減又は増加抑制できることがわかった。そして、バイオレットライトによる光刺激でのこうした効果の知見に基づき、本発明に係る血中グルコース濃度の低減又は増加抑制方法及び装置を完成するに至った。 [Device and method for reducing or increasing blood glucose concentration]
The present inventors further studied the effect of violet light on blood glucose levels. As a result, it was found that the blood glucose level could be reduced or increased by the photostimulation by irradiation with violet light. Then, based on the knowledge of such effects of light stimulation with violet light, the inventors have completed the method and apparatus for reducing or increasing the blood glucose level according to the present invention.
本発明者らは、さらにバイオレットライトによる体温への影響についての研究を行った。その結果、バイオレットライトの照射による光刺激により、体温低下を促進できることがわかった。そして、バイオレットライトによる光刺激でのこうした効果の知見に基づき、本発明に係る体温低下促進方法及び装置を完成するに至った。 [Body temperature reduction acceleration device and method]
The present inventors further conducted research on the effect of violet light on body temperature. As a result, it was found that the photo-stimulation caused by the irradiation of violet light could accelerate the decrease in body temperature. Then, based on the knowledge of such effects of light stimulation by violet light, the inventors have completed the method and apparatus for promoting a decrease in body temperature according to the present invention.
本発明者らは、さらにバイオレットライトによる体重への影響についての研究を行った。その結果、バイオレットライトの照射による光刺激により、体重増加抑制を促進できることがわかった。そして、バイオレットライトによる光刺激でのこうした効果の知見に基づき、本発明に係る体重増加抑制方法及び装置を完成するに至った。 [Weight gain suppression device and method]
The present inventors further conducted research on the effects of violet light on body weight. As a result, it was found that light stimulation by irradiation with violet light could promote suppression of weight gain. Then, based on the knowledge of such effects of light stimulation with violet light, the inventors completed the method and apparatus for suppressing weight gain according to the present invention.
本発明者らは、さらにバイオレットライトによる副交感神経への影響についての研究を行った。その結果、バイオレットライトの照射による光刺激により、副交感神経の活性化を促進できることがわかった。そして、バイオレットライトによる光刺激でのこうした効果の知見に基づき、本発明に係る副交感神経活性化促進方法及び装置を完成するに至った。 [Device and method for promoting parasympathetic nerve activation]
The present inventors further conducted research on the effects of violet light on parasympathetic nerves. As a result, it was found that the activation of parasympathetic nerves can be promoted by light stimulation by irradiating violet light. Then, based on the knowledge of such an effect of light stimulation by violet light, the inventors completed the parasympathetic nerve activation promoting method and apparatus according to the present invention.
本発明者らは、さらにバイオレットライトによる脳血流及び脳酸素濃度への影響についての研究を行った(脳の構造については図1を参照)。その結果、バイオレットライトの照射による光刺激により、脳血流及び脳酸素濃度の増加を促進できることがわかった。そして、バイオレットライトによる光刺激でのこうした効果の知見に基づき、本発明に係る脳血流及び脳酸素濃度増加促進方法及び装置を完成するに至った。 [Cerebral blood flow and cerebral oxygen concentration increase promoting device and method]
The present inventors further studied the effects of violet light on cerebral blood flow and cerebral oxygen concentration (see FIG. 1 for brain structure). As a result, it was found that the increase in cerebral blood flow and cerebral oxygen concentration can be promoted by light stimulation by irradiating violet light. Then, based on the knowledge of such effects of optical stimulation with violet light, the inventors completed the method and apparatus for promoting an increase in cerebral blood flow and cerebral oxygen concentration according to the present invention.
本発明者らは、さらにバイオレットライトによる生体への好ましい影響に鑑み、バイオレットライトの照射による光刺激を利用した光環境改善装置及び方法を完成するに至った。 [Light environment improvement device and method]
In view of the positive effects of violet light on living organisms, the present inventors have completed a device and method for improving the light environment that utilizes the light stimulation of violet light irradiation.
以下、短波長光の受光による身体への影響について順に詳細に説明する。なお、本明細書では、バイオレットライトを「VL」とも表す。バイオレットライトは360~400nmの波長光を用い、放射照度で0.5~1000μW/cm2の範囲内で点滅照射した。 (Influence on the body by receiving short-wavelength light)
In the following, the influence of short-wavelength light reception on the body will be described in detail. In this specification, violet light is also expressed as "VL". Violet light used light with a wavelength of 360 to 400 nm, and flashing irradiation was performed within the irradiance range of 0.5 to 1000 μW/cm 2 .
バイオレットライトを午前中9時10分から12時13分までの約3時間、バイオレットライトLED付属したメガネ型バイオレットライト照射装置によって男女3名ずつ計6名(平均年齢23.2±0.9歳)へ10日間照射した。バイオレットライト照射する前に9日間、光刺激なしの日の計測との比較を行っている。光照射あり、もしくは光照射なしの条件での、光刺激中もしくは光刺激した日の就寝1時間前、就寝時の被験者の体温測定を毎日行った。以下の表1および2ならびに図6および7に示される結果から、就寝時の体温低下が有意に光刺激によって誘発されていることから、体温の階日リズムの修正と睡眠誘導が促進されていることが考えられる。 (Effect of violet light irradiation on body temperature)
Violet light for about 3 hours from 9:10 to 12:13 in the morning, 6 people (average age 23.2 ± 0.9 years old), 3 men and 3 women, using a glasses-type violet light irradiation device with a violet light LED. were irradiated for 10 days. A comparison is made with measurements taken on days without light stimulation for 9 days before irradiation with violet light. The body temperature of the subjects was measured every day, one hour before bedtime and at bedtime during or on the day of light stimulation, with or without light irradiation. From the results shown in Tables 1 and 2 and FIGS. 6 and 7 below, since the decrease in body temperature at bedtime is significantly induced by light stimulation, the correction of the circadian rhythm of body temperature and the induction of sleep are promoted. can be considered.
バイオレットライトを午前中9時10分から12時13分までの約3時間、バイオレットライトLED付属したメガネ型バイオレットライト照射装置によって男女3名ずつ計6名(平均年齢23.2±0.9歳)へ10日間照射した。バイオレットライト照射する前に9日間、光刺激なしの日の計測との比較を行っている。光照射あり、もしくは光照射なしの条件下で、間質液中グルコース濃度を24時間測定した。昼食後の間質液中グルコース濃度を測定した結果、表3に示されるように、光照射群ではグルコース濃度の上昇が抑制されている(有意水準1%で平均値に差がある(p<0.01))。この結果から、食事による血糖値の上昇を抑制する機能がバイオレットライトの光照射によって得られることが分かる。 (Effect of violet light irradiation on blood sugar level)
Violet light for about 3 hours from 9:10 to 12:13 in the morning, 6 people (average age 23.2 ± 0.9 years old), 3 men and 3 women, using a glasses-type violet light irradiation device with a violet light LED. were irradiated for 10 days. A comparison is made with measurements taken on days without light stimulation for 9 days before irradiation with violet light. Glucose concentrations in interstitial fluid were measured for 24 hours under conditions with and without light irradiation. As a result of measuring the glucose concentration in the interstitial fluid after lunch, as shown in Table 3, the increase in glucose concentration was suppressed in the light irradiation group (there is a difference in the mean value at the significance level of 1% (p < 0.01)). From these results, it can be seen that the violet light irradiation has the function of suppressing the increase in blood sugar level caused by meals.
44週齢のマウス(C57Bl6/J)マウスを白色LEDの環境(cWL)と、白色のLEDとバイオレットライトLEDを組み合わせた光環境(cWL+cVL)下で飼育し、直腸温度計を用いて午前中の10~12時の間に体重を測定した(それぞれn=40)。観察は70週齢まで行った。その結果、太陽光に近い光環境を室内にて再現した白色+バイオレットライトの光環境で、体重の低下が観察された(図9)。低体温の遺伝子操作されたマウスや、カロリー制限、成長ホルモンGH欠損マウスなどでは寿命が延長され、体重に対する酸素消費量が多いなど代謝が活発化していることが知られている(Conti et al., Science 03 Nov 2006: Vol. 314, Issue 5800, pp. 825-828, DOI: 10.1126/science.1132191; Bartke & Westbrook, Front. Genet., 13 December 2012, https://doi.org/10.3389/fgene.2012.00288)。バイオレットライトの光刺激は、代謝を活性化するなど体重低下を制御することが可能であることが考えられる。 (Effect of violet light on body weight)
44-week-old mice (C57Bl6/J) were bred under a white LED environment (cWL) and a light environment combining a white LED and a violet light LED (cWL+cVL), and were measured using a rectal thermometer in the morning. Body weights were measured between 10 and 12 hours (n=40 each). Observation was continued until 70 weeks of age. As a result, a decrease in body weight was observed in a light environment of white + violet light that reproduced a light environment close to sunlight indoors (Fig. 9). Genetically engineered hypothermic mice, calorie-restricted mice, and growth hormone GH-deficient mice are known to have extended lifespans and increased metabolic activity, such as high oxygen consumption relative to body weight (Conti et al. , Science 03 Nov 2006: Vol. 314, Issue 5800, pp. 825-828, DOI: 10.1126/science.1132191; Bartke & Westbrook, Front. Genet., 13 December 2012, https://doi.org/10.3389/ fgene.2012.00288). Violet light stimulation is thought to be able to control weight loss by activating metabolism.
バイオレットライトを午前中9時10分から12時13分までの約3時間、バイオレットライトLED付属したメガネ型バイオレットライト照射装置によって男女3名ずつ計6名(平均年齢23.2±0.9歳)へ10日間照射した。バイオレットライト照射する前に9日間、光刺激なしの日の計測との比較を行っている。涙液を、ストリップメニスコメトリ検査紙を用いて、光照射時間帯の9時間に測定し、再度光照射時間帯後の12時13分以降に測定している。通常、涙液は午前中から午後にかけて減少するが、表4および図10に示されるように、バイオレットライト照射によって涙液が増加している。この結果はバイオレットライトが涙液を促進すると同時に、涙液の概日周期による低下を抑制していることが考えられる。涙液量の増加は、ドライアイや涙液量の低下に伴う角膜性疾患の防止と治療効果が期待される。 (Effect of violet light on tear volume)
Violet light for about 3 hours from 9:10 to 12:13 in the morning, 6 people (average age 23.2 ± 0.9 years old), 3 men and 3 women, using a glasses-type violet light irradiation device with a violet light LED. were irradiated for 10 days. A comparison is made with measurements taken on days without light stimulation for 9 days before irradiation with violet light. Tear fluid was measured using a strip meniscometry test paper at 9 hours of the light exposure period and again after 12:13 after the light exposure period. Normally, tear fluid decreases from morning to afternoon, but as shown in Table 4 and FIG. 10, violet light irradiation increases tear fluid. This result suggests that violet light promotes tear production and at the same time suppresses the reduction of tear production due to the circadian cycle. Increased tear volume is expected to be effective in preventing and treating dry eye and corneal diseases associated with decreased tear volume.
バイオレットライトを午前中9時10分から12時13分までの約3時間、バイオレットライトLED付属したメガネ型バイオレットライト照射装置によって男女3名ずつ計6名(平均年齢23.2±0.9歳)へ10日間照射した。心拍数をバイオレットライト刺激の有無中の3時間測定した。心拍数の測定によって0.004~0.15Hzの周波数帯のパワースペクトルLF(低周波 ms2)と0.15~0.4Hzの周波帯のパワースペクトルHF(高周波 ms2)を抽出し、LF(低周波)の比率とHF(高周波)のパワーの比率を計測した。数値が高いと交感神経優位を、低い場合は副交感神経優位を示している。表5に示されているように、バイオレットライト照射によって、LH/HF比率が低下し、副交感神経優位になっていることが示唆される。これらの結果は、バイオレットライト照射によって副交感神経優位となり、リラックス効果、インスリン分泌の促進、血流の促進効果が得られることが理解される。 (Effect of violet light on parasympathetic nerves)
Violet light for about 3 hours from 9:10 to 12:13 in the morning, 6 people (average age 23.2 ± 0.9 years old), 3 men and 3 women, using a glasses-type violet light irradiation device with a violet light LED. were irradiated for 10 days. Heart rate was measured for 3 hours with and without violet light stimulation. By measuring the heart rate, the power spectrum LF (low frequency ms 2 ) in the frequency band of 0.004 to 0.15 Hz and the power spectrum HF (high frequency ms 2 ) in the frequency band of 0.15 to 0.4 Hz are extracted, and LF (low frequency) ratio and the ratio of HF (high frequency) power were measured. A high value indicates sympathetic nerve dominance, and a low value indicates parasympathetic nerve dominance. As shown in Table 5, violet light irradiation reduces the LH/HF ratio, suggesting parasympathetic nerve dominance. From these results, it is understood that irradiation with violet light makes the parasympathetic nervous system dominant, and that relaxation effects, promotion of insulin secretion, and promotion of blood flow can be obtained.
バイオレットライトを被験者5名に20分間照射し、30分間前頭前野における脳酸素濃度を75msのサンプリング間隔にて、脳血流動態計測NIRS(近赤外分光法)を用いて測定した。実験は、安静閉眼5分、作業20分、安静閉眼5分を1セットとし、作業20分間に光照射を行った。安静閉眼時の脳血流動態計測を行っている。血中酸素化ヘモグロビン濃度(Oxy-Hb)と血中脱酸素化ヘモグロビン濃度(Deoxy-Hb)を解析している。図11に示されているように、Oxy-Hb分散がバイオレットライト照射によって増加することから、脳血流の増大と、脳の活性化が理解される。 (Effect of violet light irradiation on cerebral blood flow)
Five subjects were irradiated with violet light for 20 minutes, and the cerebral oxygen concentration in the prefrontal cortex for 30 minutes was measured using cerebral hemodynamic measurement NIRS (near infrared spectroscopy) at a sampling interval of 75 ms. In the experiment, one set consisted of 5 minutes of rest with eyes closed, 20 minutes of work, and 5 minutes of rest with eyes closed, and light irradiation was performed during 20 minutes of work. Cerebral hemodynamics are being measured while the eyes are closed at rest. Blood oxygenated hemoglobin concentration (Oxy-Hb) and blood deoxygenated hemoglobin concentration (Deoxy-Hb) are analyzed. As shown in FIG. 11, the Oxy-Hb dispersion increased by violet light irradiation, which indicates an increase in cerebral blood flow and activation of the brain.
男性6名(年齢22.63±0.7)へ午前9時から11時までの2時間バイオレットライトを照射し、24時以降の睡眠時における睡眠深度と質を測定した。脳波・眼球運動・心電図・筋電図・呼吸曲線・いびき・動脈血酸素飽和度などの生体活動を、一晩にわたって測定する検査する終夜睡眠ポリグラフ検査(PSG検査)を1人の被験者あたりに3回行っている。PSG検査の解析によって、WK、N1、N2、N3、REMの5段階で睡眠段階を評価することができる。睡眠はWKからREMに従って深い睡眠となる。図12に示されているように、バイオレットライト照射によって、N1の浅い睡眠時間が短縮し、N2の睡眠が延長している。また、眠りが浅く、夜中にしばしば目がさめる症状の中途覚醒が減少している。これらのバイオレットライトの効果は、日光を浴びた際の睡眠への効果と同程度の高い効果が得られている。これらの結果は、バイオレットライトの照射が睡眠深度と質を向上させ、睡眠障害やそれに関する疾患を予防、治療できることを示唆している。 (Effect of violet light irradiation on sleep quality)
Six men (age 22.63±0.7) were irradiated with violet light for 2 hours from 9:00 am to 11:00 am, and the depth and quality of sleep after 24:00 were measured. All-night polysomnography (PSG test), which measures biological activity such as electroencephalogram, eye movement, electrocardiogram, electromyogram, respiratory curve, snoring, arterial blood oxygen saturation, etc., three times per subject. Is going. Analysis of the PSG test allows assessment of sleep stages in five stages: WK, N1, N2, N3, and REM. Sleep becomes deep sleep from WK to REM. As shown in FIG. 12, violet light irradiation shortens light sleep time in N1 and prolongs sleep in N2. In addition, the symptoms of light sleep and frequent awakening in the middle of the night are reduced. The effect of these violet lights is as high as the effect on sleep when exposed to sunlight. These results suggest that violet light irradiation can improve the depth and quality of sleep, and prevent and treat sleep disorders and related diseases.
光を発する少なくとも1つの光源と、前記光源を駆動する駆動回路と、を有し、前記光源が発する光は、生体へ照射することによって生体機能制御効果を生じさせる特定波長の光である、光刺激による生体機能制御装置。
(付記2)
光を発する少なくとも1つの光源と、前記光源を駆動する駆動回路と、を有し、前記光源が発する光は、生体へ照射することによって涙液量増加促進効果を生じさせる特定波長の光である、光刺激による涙液量増加促進装置。
(付記3)
光を発する少なくとも1つの光源と、前記光源を駆動する駆動回路と、を有し、前記光源が発する光は、生体へ照射することによって睡眠効率又は睡眠の質の改善効果を生じさせる特定波長の光である、光刺激による睡眠効率又は睡眠の質の改善装置。
(付記4)
光を発する少なくとも1つの光源と、前記光源を駆動する駆動回路と、を有し、前記光源が発する光は、生体へ照射することによって血中グルコース濃度低減又は増加抑制効果を生じさせる特定波長の光である、光刺激による血中グルコース濃度低減又は増加抑制装置。
(付記5)
光を発する少なくとも1つの光源と、前記光源を駆動する駆動回路と、を有し、前記光源が発する光は、生体へ照射することによって体温低下促進効果を生じさせる特定波長の光である、光刺激による体温低下促進装置。
(付記6)
光を発する少なくとも1つの光源と、前記光源を駆動する駆動回路と、を有し、前記光源が発する光は、生体へ照射することによって体重増加抑制効果を生じさせる特定波長の光である、光刺激による体重増加抑制装置。
(付記7)
光を発する少なくとも1つの光源と、前記光源を駆動する駆動回路と、を有し、前記光源が発する光は、生体へ照射することによって副交感神経活性化効果を生じさせる特定波長の光である、光刺激による副交感神経活性化促進装置。
(付記8)
光を発する少なくとも1つの光源と、前記光源を駆動する駆動回路と、を有し、前記光源が発する光は、生体へ照射することによって脳血流及び脳酸素濃度増加促進効果を生じさせる特定波長の光である、光刺激による脳血流及び脳酸素濃度増加促進装置。
(付記9)
光を発する少なくとも1つの光源と、前記光源を駆動する駆動回路と、を有し、前記光源が発する光は、生体へ照射することによって生体機能制御効果を生じさせる特定波長の光である、光刺激による光環境改善装置。
(付記10)
前記光はバイオレットライトである、付記1~9のいずれか一項記載の装置。
(付記11)
前記特定波長は350~400nmを含む、付記1~10のいずれか一項記載の装置。
(付記12)
前記特定波長は約380nmを含む、付記11記載の装置。
(付記13)
光の点滅周波数が0Hz又は30~70Hzである、付記1~12のいずれか1項記載の装置。
(付記14)
前記点滅周波数は0Hz又は35~60Hzである、付記13記載の装置。
(付記15)
前記点滅周波数は0Hz又は約40Hzである、付記14記載の装置。
(付記16)
光の照射条件が、前記光源の照射時間を含む、付記1~15のいずれか1項記載の装置。
(付記17)
前記光源は、光源付きめがね若しくはめがねフレーム、卓上光源、移動体端末装着光源、顔前又は近傍設置型光源、携帯光源、室内照明、又は卓上スタンドである、付記1~16のいずれか1項記載の装置。
(付記18)
付記1~17のいずれか一項記載の装置の作動方法であって、前記装置は、特定波長の光を常灯又は特定の点滅周波数で生体に照射する光源と、前記光源の点滅周波数を制御する制御部とを備え、前記制御部が、前記光源の点滅周波数を0Hz又は30~75Hzの範囲において制御する段階、前記光源が、350~400nmの範囲の波長の光を生体に照射する段階を含む、作動方法。
(付記19)
前記特定波長が、約380nmである、付記18記載の作動方法。
(付記20)
前記特定の点滅周波数が、0Hz又は約40Hzである、付記18または19記載の作動方法。
(付記21)
前記制御部が、前記特定波長の光を照射する時間又は期間を制御する機能をさらに備え、前記制御部が、照射時間を10秒~100時間の範囲で制御する段階をさらに含む、付記18~20のいずれか一項記載の作動方法。
(付記22)
特定波長の光を常灯又は特定の点滅周波数で生体に照射する光源と、前記光源の点滅周波数を制御する制御部とを備えた装置に付記17~21のいずれか一項に記載の作動方法を実行させるコンピュータプログラム。
(付記23)
処置を必要とする対象において、
a)涙液量の増加を促進する、
b)睡眠効率又は睡眠の質を改善する、
c)血中グルコース濃度を低減又は増加抑制する、
d)体温低下を促進する、
e)体重増加を抑制する、
f)副交感神経の活性化を促進する、又は
g)脳血流及び脳酸素濃度増加を促進する
ための方法であって、対象に対して350~400nmの範囲の波長の光を0Hz又は30~75Hzの範囲の点滅周波数で生体に照射する段階を含み、それにより、前記光を受けた前記生体において上記効果が得られる、方法。
(付記24)
バイオレットライトを常灯又は特定の点滅周波数で生体に照射して、
a)角膜性疾患の予防又は治療するための、
b)ドライアイを予防又は治療するための、
c)睡眠障害やそれに関する疾患の予防又は治療するための、
d)睡眠障害を予防又は治療するための、
e)時差ぼけを解消するための、
f)睡眠を導入するための、
g)眠気を抑制するための、
h)糖尿病を予防するための、
i)慢性腎障害、動脈硬化、脳梗塞、又は痛風を予防するための、
j)肥満を防止するための、
k)老化関連疾患を予防するための、
l)代謝を活性化するための、
m)脂肪燃焼を促進するための、
n)ミトコンドリアの活性化を促進するための、
o)ストレス又は疲労感を軽減するための、又は
p)便秘を解消するための、
装置であって、前記バイオレットライトを発光する光源と、前記バイオレットライトを常灯又は特定の点滅周波数とする発光周期制御部と、前記バイオレットライトを特定の時間又は特定の期間照射する発光時間制御部と、を備え、上記効果を得るために使用される装置。
(付記25)
バイオレットライトの常灯光を生体に照射して、
a)角膜性疾患の予防又は治療する、
b)ドライアイを予防又は治療する、
c)睡眠障害やそれに関する疾患の予防又は治療する、
d)睡眠障害を予防又は治療する、
e)時差ぼけを解消する、
f)睡眠を導入する、
g)眠気を抑制する、
h)糖尿病を予防する、
i)慢性腎障害、動脈硬化、脳梗塞、又は痛風を予防する、
j)肥満を防止する、
k)老化関連疾患を予防する、
l)代謝を活性化する、
m)脂肪燃焼を促進する、
n)ミトコンドリアの活性化を促進する、
o)ストレス若しくは疲労感を軽減する、又は
p)便秘を解消する、
装置であって、前記バイオレットライトを発光する光源と、前記バイオレットライトを特定の時間又は特定の期間照射する発光時間制御部と、を備える装置。
(付記26)
光を発する少なくとも1つの光源と、前記光源を駆動する駆動回路と、を有し、前記光源が発する光は、生体へ照射することによって、
a)角膜性疾患の予防又は治療する、
b)ドライアイを予防又は治療する、
c)睡眠障害やそれに関する疾患の予防又は治療する、
d)睡眠障害を予防又は治療する、
e)時差ぼけを解消する、
f)睡眠を導入する、
g)眠気を抑制する、
h)糖尿病を予防する、
i)慢性腎障害、動脈硬化、脳梗塞、又は痛風を予防する、
j)肥満を防止する、
k)老化関連疾患を予防する、
l)代謝を活性化する、
m)脂肪燃焼を促進する、
n)ミトコンドリアの活性化を促進する、
o)ストレス若しくは疲労感を軽減する、又は
p)便秘を解消する、
効果を生じさせる特定波長の光である、光刺激による装置。
(付記27)
a)角膜性疾患の予防又は治療する、
b)ドライアイを予防又は治療する、
c)睡眠障害やそれに関する疾患の予防又は治療する、
d)睡眠障害を予防又は治療する、
e)時差ぼけを解消する、
f)睡眠を導入する、
g)眠気を抑制する、
h)糖尿病を予防する、
i)慢性腎障害、動脈硬化、脳梗塞、又は痛風を予防する、
j)肥満を防止する、
k)老化関連疾患を予防する、
l)代謝を活性化する、
m)脂肪燃焼を促進する、
n)ミトコンドリアの活性化を促進する、
o)ストレス若しくは疲労感を軽減する、又は
p)便秘を解消する、
ために用いるための装置の作動方法であって、前記装置は、特定波長の光を常灯又は特定の点滅周波数で生体に照射する光源と、前記光源の点滅周波数を制御する制御部とを備え、前記制御部が、前記光源の点滅周波数を0Hz又は30~75Hzの範囲において制御する段階、前記光源が、350~400nmの範囲の波長の光を生体に照射する段階を含む、作動方法。
(付記28)
特定波長の光を常灯又は特定の点滅周波数で生体に照射する光源と、前記光源の点滅周波数を制御する制御部とを備えた装置に付記26の作動方法を実行させるコンピュータプログラム。
(付記29)
処置を必要とする対象において、
a)角膜性疾患の予防又は治療する、
b)ドライアイを予防又は治療する、
c)睡眠障害やそれに関する疾患の予防又は治療する、
d)睡眠障害を予防又は治療する、
e)時差ぼけを解消する、
f)睡眠を導入する、
g)眠気を抑制する、
h)糖尿病を予防する、
i)慢性腎障害、動脈硬化、脳梗塞、又は痛風を予防する、
j)肥満を防止する、
k)老化関連疾患を予防する、
l)代謝を活性化する、
m)脂肪燃焼を促進する、
n)ミトコンドリアの活性化を促進する、
o)ストレス若しくは疲労感を軽減する、又は
p)便秘を解消する、
ための方法であって、対象に対して350~400nmの範囲の波長の光を0Hz又は30~75Hzの範囲の点滅周波数で生体に照射する段階を含み、それにより、前記光を受けた前記生体において上記効果が得られる、方法。
(付記30)
バイオレットライトを通過させるガラス、めがねレンズ又はコンタクトレンズを含む、光刺激による光環境改善器具。
(付記31)
処置を必要とする対象において、
a)涙液量の増加を促進する、
b)睡眠効率又は睡眠の質を改善する、
c)血中グルコース濃度を低減又は増加抑制する、
d)体温低下を促進する、
e)体重増加を抑制する、
f)副交感神経の活性化を促進する、又は
g)脳血流及び脳酸素濃度増加を促進する
ための器具であって、バイオレットライトを通過させるガラス、めがねレンズ又はコンタクトレンズを含む、器具。
(付記32)
処置を必要とする対象において、
a)角膜性疾患の予防又は治療する、
b)ドライアイを予防又は治療する、
c)睡眠障害やそれに関する疾患の予防又は治療する、
d)睡眠障害を予防又は治療する、
e)時差ぼけを解消する、
f)睡眠を導入する、
g)眠気を抑制する、
h)糖尿病を予防する、
i)慢性腎障害、動脈硬化、脳梗塞、又は痛風を予防する、
j)肥満を防止する、
k)老化関連疾患を予防する、
l)代謝を活性化する、
m)脂肪燃焼を促進する、
n)ミトコンドリアの活性化を促進する、
o)ストレス若しくは疲労感を軽減する、又は
p)便秘を解消する、
ための器具であって、バイオレットライトを通過させるガラス、めがねレンズ又はコンタクトレンズを含む、器具。
(付記33)
処置を必要とする対象において生体機能制御効果を生じさせるための方法であって、対象に対して特定波長の光を照射することを含む、方法。
(付記34)
前記駆動回路が、光源及び少なくとも1つのメモリに通信可能に接続された少なくとも1つのプロセッサと、プロセッサが実行可能な命令を格納するための少なくとも1つのメモリとを含む、付記1~9のいずれか一項記載の装置。
(付記35)
光を発する少なくとも1つの光源と、
前記光源を駆動する駆動回路と、
を有し、
前記駆動回路は、光源及び少なくとも1つのメモリに通信可能に接続された少なくとも1つのプロセッサと、プロセッサが実行可能な命令を格納するための少なくとも1つのメモリとを含み、
前記光源が、生体へ照射することによって生体機能制御効果を生じさせる特定波長の光を発するように構成されている、
光刺激による生体機能制御装置。
(付記36)
命令が格納された非一時的(non-transitory)なコンピュータ可読媒体であって、命令がプロセッサによって実行されると、以下のステップを実行することができる、コンピュータ可読媒体:
特定波長の光を常灯又は特定の点滅周波数で生体に照射する光源と、前記光源の点滅周波数を制御する制御部とを備える装置に対して、
前記制御部が、前記光源の点滅周波数を0Hz又は30~75Hzの範囲において制御するように前記装置を作動させるステップ、並びに
前記光源が、350~400nmの範囲の波長の光を生体に照射するように前記装置を作動させるステップ。
(Appendix 1)
Light comprising at least one light source that emits light and a drive circuit that drives the light source, wherein the light emitted by the light source is light of a specific wavelength that produces a biological function control effect when applied to a living body. A biological function control device using stimulation.
(Appendix 2)
It has at least one light source that emits light and a drive circuit that drives the light source, and the light emitted by the light source is light of a specific wavelength that, when irradiated to a living body, produces an effect of promoting an increase in the amount of tear fluid. , A device that promotes increased tear volume by light stimulation.
(Appendix 3)
At least one light source that emits light, and a drive circuit that drives the light source, and the light emitted by the light source has a specific wavelength that improves sleep efficiency or sleep quality when irradiated to a living body. A device for improving sleep efficiency or sleep quality by light stimulation.
(Appendix 4)
At least one light source that emits light, and a drive circuit that drives the light source, and the light emitted by the light source has a specific wavelength that causes an effect of reducing or suppressing an increase in blood glucose concentration by irradiating a living body. A light-stimulated blood glucose level reduction or increase inhibitory device.
(Appendix 5)
Light comprising at least one light source that emits light and a drive circuit that drives the light source, wherein the light emitted by the light source is light of a specific wavelength that causes a body temperature lowering effect when irradiated to a living body. A device that promotes hypothermia through stimulation.
(Appendix 6)
At least one light source that emits light, and a drive circuit that drives the light source, wherein the light emitted by the light source is light of a specific wavelength that produces an effect of suppressing weight gain when applied to a living body. A device for suppressing weight gain by stimulation.
(Appendix 7)
At least one light source that emits light and a drive circuit that drives the light source, and the light emitted by the light source is light of a specific wavelength that causes a parasympathetic nerve activation effect when irradiated to a living body. Device for promoting parasympathetic nerve activation by light stimulation.
(Appendix 8)
At least one light source that emits light, and a drive circuit that drives the light source, wherein the light emitted by the light source has a specific wavelength that promotes an increase in cerebral blood flow and cerebral oxygen concentration when applied to a living body. A device for promoting cerebral blood flow and cerebral oxygen concentration increase by optical stimulation.
(Appendix 9)
Light comprising at least one light source that emits light and a drive circuit that drives the light source, wherein the light emitted by the light source is light of a specific wavelength that produces a biological function control effect when applied to a living body. Light environment improvement device by stimulation.
(Appendix 10)
10. The device according to any one of the clauses 1-9, wherein the light is violet light.
(Appendix 11)
11. The device according to any one of clauses 1-10, wherein said specific wavelength comprises 350-400 nm.
(Appendix 12)
12. The apparatus of Clause 11, wherein the specific wavelength comprises approximately 380 nm.
(Appendix 13)
13. The device according to any one of the appendices 1-12, wherein the flashing frequency of the light is 0 Hz or 30-70 Hz.
(Appendix 14)
14. The device according to clause 13, wherein the blinking frequency is 0 Hz or 35-60 Hz.
(Appendix 15)
15. The device of clause 14, wherein the blinking frequency is 0 Hz or about 40 Hz.
(Appendix 16)
16. The apparatus according to any one of
(Appendix 17)
17. The light source according to any one of
(Appendix 18)
18. The method of operating the device according to any one of
(Appendix 19)
19. The method of operation of claim 18, wherein said specific wavelength is approximately 380 nm.
(Appendix 20)
20. The method of operation according to clause 18 or 19, wherein said particular blinking frequency is 0 Hz or about 40 Hz.
(Appendix 21)
Supplementary notes 18 to 18, wherein the control unit further comprises a function of controlling the time or period of irradiation with the light of the specific wavelength, and further comprising the step of controlling the irradiation time in the range of 10 seconds to 100 hours. 21. A method of operation according to any one of
(Appendix 22)
22. The operation method according to any one of appendices 17 to 21, for a device comprising a light source that irradiates a living body with light of a specific wavelength at a constant light or a specific blinking frequency, and a control unit that controls the blinking frequency of the light source. computer program that causes the
(Appendix 23)
In a subject in need of treatment,
a) promoting increased tear volume,
b) improve sleep efficiency or sleep quality;
c) reduce or inhibit increase in blood glucose concentration,
d) promoting hypothermia,
e) suppress weight gain,
f) promoting parasympathetic activation, or g) promoting cerebral blood flow and cerebral oxygenation, comprising exposing a subject to light in the wavelength range of 350-400 nm at 0 Hz or 30- A method comprising irradiating a living body with a flickering frequency in the range of 75 Hz, whereby said effect is obtained in said living body receiving said light.
(Appendix 24)
Irradiate the living body with a violet light at a constant light or a specific blinking frequency,
a) for the prevention or treatment of corneal diseases,
b) for preventing or treating dry eye,
c) for the prevention or treatment of sleep disorders and related diseases;
d) to prevent or treat sleep disorders,
e) to combat jet lag,
f) to induce sleep,
g) to suppress drowsiness,
h) to prevent diabetes,
i) to prevent chronic kidney damage, arteriosclerosis, cerebral infarction, or gout,
j) to prevent obesity,
k) for preventing aging-related diseases,
l) to activate the metabolism,
m) to promote fat burning,
n) to promote mitochondrial activation,
o) to relieve stress or fatigue, or p) to relieve constipation,
A device comprising: a light source that emits the violet light; a light emission cycle control unit that makes the violet light a constant light or a specific blinking frequency; and a light emission time control unit that irradiates the violet light for a specific time or for a specific period. and a device used to obtain the above effect.
(Appendix 25)
Irradiate the living body with the constant light of the violet light,
a) prevent or treat corneal diseases,
b) prevent or treat dry eye,
c) prevent or treat sleep disorders and related diseases;
d) prevent or treat sleep disorders;
e) relieve jet lag,
f) induce sleep,
g) suppress drowsiness,
h) prevent diabetes,
i) prevent chronic kidney damage, arteriosclerosis, stroke, or gout;
j) prevent obesity,
k) prevent aging-related diseases,
l) activate metabolism,
m) promote fat burning,
n) promotes mitochondrial activation;
o) reduce stress or fatigue, or p) relieve constipation,
A device comprising: a light source that emits the violet light; and a light emission time controller that irradiates the violet light for a specific time or for a specific period.
(Appendix 26)
At least one light source that emits light, and a driving circuit that drives the light source, wherein the light emitted by the light source irradiates a living body,
a) prevent or treat corneal diseases,
b) prevent or treat dry eye,
c) prevent or treat sleep disorders and related diseases;
d) prevent or treat sleep disorders;
e) relieve jet lag,
f) induce sleep,
g) suppress drowsiness,
h) prevent diabetes,
i) prevent chronic kidney damage, arteriosclerosis, stroke, or gout;
j) prevent obesity,
k) prevent aging-related diseases,
l) activate metabolism,
m) promote fat burning,
n) promotes mitochondrial activation;
o) reduce stress or fatigue, or p) relieve constipation,
A photo-stimulated device that is a specific wavelength of light that produces an effect.
(Appendix 27)
a) prevent or treat corneal diseases,
b) prevent or treat dry eye,
c) prevent or treat sleep disorders and related diseases;
d) prevent or treat sleep disorders;
e) relieve jet lag,
f) induce sleep,
g) suppress drowsiness,
h) prevent diabetes,
i) prevent chronic kidney damage, arteriosclerosis, stroke, or gout;
j) prevent obesity,
k) prevent aging-related diseases,
l) activate metabolism,
m) promote fat burning,
n) promotes mitochondrial activation;
o) reduce stress or fatigue, or p) relieve constipation,
A method of operating a device for use in a method for , the control unit controlling the blinking frequency of the light source in the range of 0 Hz or 30 to 75 Hz; and the light source irradiating the living body with light having a wavelength in the range of 350 to 400 nm.
(Appendix 28)
A computer program for causing an apparatus comprising a light source for irradiating a living body with light of a specific wavelength at a constant light or at a specific blinking frequency and a controller for controlling the blinking frequency of the light source to execute the operation method of appendix 26.
(Appendix 29)
In a subject in need of treatment,
a) prevent or treat corneal diseases,
b) prevent or treat dry eye,
c) prevent or treat sleep disorders and related diseases;
d) prevent or treat sleep disorders;
e) relieve jet lag,
f) induce sleep,
g) suppress drowsiness,
h) prevent diabetes,
i) prevent chronic kidney damage, arteriosclerosis, stroke, or gout;
j) prevent obesity,
k) prevent aging-related diseases,
l) activate metabolism,
m) promote fat burning,
n) promotes mitochondrial activation;
o) reduce stress or fatigue, or p) relieve constipation,
comprising the step of irradiating a subject with light having a wavelength in the range of 350-400 nm at a blinking frequency in the range of 0 Hz or 30-75 Hz, whereby said living body receiving said light A method in which the above effect is obtained.
(Appendix 30)
Devices for improving the light environment by photostimulation, including glasses, spectacle lenses or contact lenses that allow violet light to pass through.
(Appendix 31)
In a subject in need of treatment,
a) promoting increased tear volume,
b) improve sleep efficiency or sleep quality;
c) reduce or inhibit increase in blood glucose concentration,
d) promoting hypothermia,
e) suppress weight gain,
f) promoting parasympathetic activation, or g) devices for promoting cerebral blood flow and cerebral oxygenation, comprising glasses, spectacle lenses or contact lenses that allow violet light to pass through.
(Appendix 32)
In a subject in need of treatment,
a) prevent or treat corneal diseases,
b) prevent or treat dry eye,
c) prevent or treat sleep disorders and related diseases;
d) prevent or treat sleep disorders;
e) relieve jet lag,
f) induce sleep,
g) suppress drowsiness,
h) prevent diabetes,
i) prevent chronic kidney damage, arteriosclerosis, stroke, or gout;
j) prevent obesity,
k) prevent aging-related diseases,
l) activate metabolism,
m) promote fat burning,
n) promotes mitochondrial activation;
o) reduce stress or fatigue, or p) relieve constipation,
comprising glasses, spectacle lenses or contact lenses that allow violet light to pass through.
(Appendix 33)
A method for producing a biofunction-regulating effect in a subject in need of treatment, the method comprising irradiating the subject with light of a particular wavelength.
(Appendix 34)
10. Any of Clauses 1-9, wherein the drive circuitry includes at least one processor communicatively connected to a light source and at least one memory, and at least one memory for storing processor-executable instructions. A device according to
(Appendix 35)
at least one light source that emits light;
a driving circuit for driving the light source;
has
the drive circuitry includes at least one processor communicatively connected to a light source and at least one memory; and at least one memory for storing processor-executable instructions;
The light source is configured to emit light of a specific wavelength that produces a biological function control effect by irradiating the living body.
Biofunction control device by optical stimulation.
(Appendix 36)
A non-transitory computer-readable medium having instructions stored thereon that, when the instructions are executed by a processor, are capable of performing the following steps:
A device comprising a light source that irradiates a living body with light of a specific wavelength at a constant light or a specific blinking frequency, and a control unit that controls the blinking frequency of the light source,
the control unit operating the device to control the blinking frequency of the light source in the range of 0 Hz or 30 to 75 Hz; activating the device to.
Claims (23)
- 光を発する少なくとも1つの光源と、
前記光源を駆動する駆動回路と、
を有し、
前記光源が発する光は、生体へ照射することによって生体機能制御効果を生じさせる特定波長の光である、
光刺激による生体機能制御装置。 at least one light source that emits light;
a driving circuit for driving the light source;
has
The light emitted by the light source is light of a specific wavelength that produces a biological function control effect by irradiating the living body.
Biofunction control device by optical stimulation. - 光を発する少なくとも1つの光源と、
前記光源を駆動する駆動回路と、
を有し、
前記光源が発する光は、生体へ照射することによって涙液量増加促進効果を生じさせる特定波長の光である、
光刺激による涙液量増加促進装置。 at least one light source that emits light;
a driving circuit for driving the light source;
has
The light emitted by the light source is light of a specific wavelength that produces an effect of promoting tear volume increase by irradiating the living body.
A device that promotes increased tear volume by light stimulation. - 光を発する少なくとも1つの光源と、
前記光源を駆動する駆動回路と、
を有し、
前記光源が発する光は、生体へ照射することによって睡眠効率又は睡眠の質の改善効果を生じさせる特定波長の光である、
光刺激による睡眠効率又は睡眠の質の改善装置。 at least one light source that emits light;
a driving circuit for driving the light source;
has
The light emitted by the light source is light of a specific wavelength that produces an effect of improving sleep efficiency or sleep quality by irradiating a living body.
An apparatus for improving sleep efficiency or sleep quality by light stimulation. - 光を発する少なくとも1つの光源と、
前記光源を駆動する駆動回路と、
を有し、
前記光源が発する光は、生体へ照射することによって血中グルコース濃度低減又は増加抑制効果を生じさせる特定波長の光である、
光刺激による血中グルコース濃度低減又は増加抑制装置。 at least one light source that emits light;
a driving circuit for driving the light source;
has
The light emitted by the light source is light of a specific wavelength that causes an effect of suppressing blood glucose concentration reduction or increase by irradiating the living body.
A blood glucose concentration reduction or increase suppression device by light stimulation. - 光を発する少なくとも1つの光源と、
前記光源を駆動する駆動回路と、
を有し、
前記光源が発する光は、生体へ照射することによって体温低下促進効果を生じさせる特定波長の光である、
光刺激による体温低下促進装置。 at least one light source that emits light;
a driving circuit for driving the light source;
has
The light emitted by the light source is light of a specific wavelength that causes a body temperature lowering effect by irradiating the living body.
A device that promotes hypothermia by light stimulation. - 光を発する少なくとも1つの光源と、
前記光源を駆動する駆動回路と、
を有し、
前記光源が発する光は、生体へ照射することによって体重増加抑制効果を生じさせる特定波長の光である、
光刺激による体重増加抑制装置。 at least one light source that emits light;
a driving circuit for driving the light source;
has
The light emitted by the light source is light of a specific wavelength that produces an effect of suppressing weight gain by irradiating a living body.
A device for suppressing weight gain by light stimulation. - 光を発する少なくとも1つの光源と、
前記光源を駆動する駆動回路と、
を有し、
前記光源が発する光は、生体へ照射することによって副交感神経活性化効果を生じさせる特定波長の光である、
光刺激による副交感神経活性化促進装置。 at least one light source that emits light;
a driving circuit for driving the light source;
has
The light emitted by the light source is light of a specific wavelength that causes a parasympathetic nerve activation effect by irradiating the living body.
Device for promoting parasympathetic nerve activation by light stimulation. - 光を発する少なくとも1つの光源と、
前記光源を駆動する駆動回路と、
を有し、
前記光源が発する光は、生体へ照射することによって脳血流及び脳酸素濃度増加促進効果を生じさせる特定波長の光である、
光刺激による脳血流及び脳酸素濃度増加促進装置。 at least one light source that emits light;
a driving circuit for driving the light source;
has
The light emitted by the light source is light of a specific wavelength that causes an increase in cerebral blood flow and cerebral oxygen concentration by irradiating the living body.
A device for increasing cerebral blood flow and cerebral oxygen concentration by light stimulation. - 光を発する少なくとも1つの光源と、
前記光源を駆動する駆動回路と、
を有し、
前記光源が発する光は、生体へ照射することによって生体機能制御効果を生じさせる特定波長の光である、
光刺激による光環境改善装置。 at least one light source that emits light;
a driving circuit for driving the light source;
has
The light emitted by the light source is light of a specific wavelength that produces a biological function control effect by irradiating the living body.
Light environment improvement device by light stimulation. - 前記光はバイオレットライトである、請求項1~9のいずれか一項記載の装置。 The device according to any one of claims 1 to 9, wherein said light is violet light.
- 前記特定波長は350~400nmを含む、請求項1~10のいずれか一項記載の装置。 The device according to any one of claims 1 to 10, wherein said specific wavelength includes 350 to 400 nm.
- 前記特定波長は約380nmを含む、請求項11記載の装置。 12. The apparatus of claim 11, wherein said specific wavelength comprises approximately 380 nm.
- 光の点滅周波数が0Hz又は30~70Hzである、請求項1~12のいずれか1項記載の装置。 The device according to any one of claims 1 to 12, wherein the flashing frequency of the light is 0 Hz or 30 to 70 Hz.
- 前記点滅周波数は0Hz又は35~60Hzである、請求項13記載の装置。 The device according to claim 13, wherein said blinking frequency is 0 Hz or 35-60 Hz.
- 前記点滅周波数は0Hz又は約40Hzである、請求項14記載の装置。 15. The device of claim 14, wherein the flashing frequency is 0 Hz or about 40 Hz.
- 光の照射条件が、前記光源の照射時間を含む、請求項1~15のいずれか1項記載の装置。 The apparatus according to any one of claims 1 to 15, wherein the light irradiation conditions include the irradiation time of the light source.
- 前記光源は、光源付きめがね若しくはめがねフレーム、卓上光源、移動体端末装着光源、顔前又は近傍設置型光源、携帯光源、室内照明、又は卓上スタンドである、請求項1~16のいずれか1項記載の装置。 17. Any one of claims 1 to 16, wherein the light source is spectacles with a light source or a spectacle frame, desktop light source, mobile terminal-mounted light source, face-mounted light source or near-face type light source, portable light source, indoor lighting, or desktop stand. Apparatus as described.
- 請求項1~17のいずれか一項記載の装置の作動方法であって、前記装置は、特定波長の光を常灯又は特定の点滅周波数で生体に照射する光源と、前記光源の点滅周波数を制御する制御部とを備え、前記制御部が、前記光源の点滅周波数を0Hz又は30~75Hzの範囲において制御する段階、前記光源が、350~400nmの範囲の波長の光を生体に照射する段階を含む、作動方法。 18. The method of operating the device according to any one of claims 1 to 17, wherein the device comprises a light source that irradiates a living body with light of a specific wavelength at a constant light or a specific blinking frequency, and a blinking frequency of the light source. a controller for controlling, wherein the controller controls the blinking frequency of the light source in the range of 0 Hz or 30 to 75 Hz; and the light source irradiates the living body with light having a wavelength in the range of 350 to 400 nm. method of operation, including
- 前記特定波長が、約380nmである、請求項18記載の作動方法。 The method of operation according to claim 18, wherein said specific wavelength is about 380 nm.
- 前記特定の点滅周波数が、0Hz又は約40Hzである、請求項18または19記載の作動方法。 20. The method of operation according to claim 18 or 19, wherein said specific blinking frequency is 0 Hz or about 40 Hz.
- 前記制御部が、前記特定波長の光を照射する時間又は期間を制御する機能をさらに備え、前記制御部が、照射時間を10秒~100時間の範囲で制御する段階をさらに含む、請求項18~20のいずれか一項記載の作動方法。 18. The control unit further comprises a function of controlling a time or period of irradiation with the light of the specific wavelength, and further comprising a step of controlling the irradiation time within a range of 10 seconds to 100 hours. 21. A method of operation according to any one of claims 1 to 20.
- 特定波長の光を常灯又は特定の点滅周波数で生体に照射する光源と、前記光源の点滅周波数を制御する制御部とを備えた装置に請求項17~21のいずれか一項に記載の作動方法を実行させるコンピュータプログラム。 The operation according to any one of claims 17 to 21 to a device comprising a light source that irradiates a living body with light of a specific wavelength at a constant light or a specific blinking frequency, and a control unit that controls the blinking frequency of the light source. A computer program that carries out a method.
- 処置を必要とする対象において、
a)涙液量の増加を促進する、
b)睡眠効率又は睡眠の質を改善する、
c)血中グルコース濃度を低減又は増加抑制する、
d)体温低下を促進する、
e)体重増加を抑制する、
f)副交感神経の活性化を促進する、又は
g)脳血流及び脳酸素濃度増加を促進する
ための方法であって、対象に対して350~400nmの範囲の波長の光を0Hz又は30~75Hzの範囲の点滅周波数で生体に照射する段階を含み、それにより、前記光を受けた前記生体において上記効果が得られる、方法。
In a subject in need of treatment,
a) promoting increased tear volume,
b) improve sleep efficiency or sleep quality;
c) reduce or inhibit increase in blood glucose concentration,
d) promoting hypothermia,
e) suppress weight gain,
f) promoting parasympathetic activation, or g) promoting cerebral blood flow and cerebral oxygenation, comprising exposing a subject to light in the wavelength range of 350-400 nm at 0 Hz or 30- A method comprising irradiating a living body with a flickering frequency in the range of 75 Hz, whereby said effect is obtained in said living body receiving said light.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP22771543.0A EP4309728A1 (en) | 2021-03-19 | 2022-03-18 | Device for controlling biometric function via light stimulation and operation method thereof |
KR1020237035257A KR20230158655A (en) | 2021-03-19 | 2022-03-18 | Apparatus for controlling biological functions by light stimulation and method of operating the same |
CN202280022730.4A CN116997390A (en) | 2021-03-19 | 2022-03-18 | Device for controlling biological functions by optical stimulation and method for operating the same |
JP2023507199A JPWO2022196798A1 (en) | 2021-03-19 | 2022-03-18 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021046572 | 2021-03-19 | ||
JP2021-046572 | 2021-03-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022196798A1 true WO2022196798A1 (en) | 2022-09-22 |
Family
ID=83320491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2022/012620 WO2022196798A1 (en) | 2021-03-19 | 2022-03-18 | Device for controlling biometric function via light stimulation and operation method thereof |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP4309728A1 (en) |
JP (1) | JPWO2022196798A1 (en) |
KR (1) | KR20230158655A (en) |
CN (1) | CN116997390A (en) |
WO (1) | WO2022196798A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009112804A (en) * | 2007-10-18 | 2009-05-28 | Minato Ikagaku Kk | Blue light stimulation device for promoting internal production of igf-1, and method thereof |
WO2015186723A1 (en) | 2014-06-03 | 2015-12-10 | 株式会社 坪田ラボ | Myopia prevention article |
JP2020522363A (en) * | 2017-06-08 | 2020-07-30 | ドパビジョン ゲゼルシャフト ミット ベシュレンクテル ハフツング | System and method for stimulating the optic nerve |
-
2022
- 2022-03-18 KR KR1020237035257A patent/KR20230158655A/en unknown
- 2022-03-18 WO PCT/JP2022/012620 patent/WO2022196798A1/en active Application Filing
- 2022-03-18 CN CN202280022730.4A patent/CN116997390A/en active Pending
- 2022-03-18 EP EP22771543.0A patent/EP4309728A1/en active Pending
- 2022-03-18 JP JP2023507199A patent/JPWO2022196798A1/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009112804A (en) * | 2007-10-18 | 2009-05-28 | Minato Ikagaku Kk | Blue light stimulation device for promoting internal production of igf-1, and method thereof |
WO2015186723A1 (en) | 2014-06-03 | 2015-12-10 | 株式会社 坪田ラボ | Myopia prevention article |
JP2020522363A (en) * | 2017-06-08 | 2020-07-30 | ドパビジョン ゲゼルシャフト ミット ベシュレンクテル ハフツング | System and method for stimulating the optic nerve |
Non-Patent Citations (7)
Title |
---|
BARTKEWESTBROOK, FRONT. GENET, 13 December 2012 (2012-12-13), Retrieved from the Internet <URL:https://doi.org/10.3389/fgene.2012.00288> |
CONTI ET AL., SCIENCE, vol. 314, 3 November 2006 (2006-11-03), pages 825 - 828 |
HIDEMASA TORII ET AL., EBIOMEDICINE, Retrieved from the Internet <URL:http://dx.doi.org/10.1016/j.ebiom.2016.12.007> |
KAZUO TSUBOTASHUEISHA, BLUE LIGHT HAZARD, 20 November 2013 (2013-11-20) |
KOTANI ET AL., AGING CELL, vol. 4, 2005, pages 147 - 155, Retrieved from the Internet <URL:https://doi.org/10.1111/j.1474-9726.2005.00157.x> |
LANE ET AL., PNAS, vol. 93, no. 9, 30 April 1996 (1996-04-30), pages 4159 - 4164, Retrieved from the Internet <URL:https://doi.org/10.1073/pnas.93.9.4159> |
MEGUMI HATORIKAZUO TSUBOTA, JAPANESE SOCIETY OF ANTI-AGING MEDICINE MAGAZINE, no. 392, 2015 |
Also Published As
Publication number | Publication date |
---|---|
KR20230158655A (en) | 2023-11-21 |
CN116997390A (en) | 2023-11-03 |
JPWO2022196798A1 (en) | 2022-09-22 |
EP4309728A1 (en) | 2024-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wahl et al. | The inner clock—Blue light sets the human rhythm | |
Turner et al. | Circadian photoreception: ageing and the eye’s important role in systemic health | |
US11013883B2 (en) | Stress reduction and sleep promotion system | |
US8790383B2 (en) | Light therapy modality | |
US10384070B2 (en) | Spectacles for light therapy | |
Turner et al. | The role of environmental light in sleep and health: effects of ocular aging and cataract surgery | |
JP6559666B2 (en) | System and method for providing phototherapy and correcting circadian rhythm | |
Cajochen | Alerting effects of light | |
JP2020534042A (en) | Automatic personalized brain conditioning system and method using photobiomodulation | |
US20060106437A1 (en) | Method for modifying or resetting the circadian cycle using short wavelength light | |
US20140277292A1 (en) | Systems and methods for light modulation of autonomic tone or function | |
JP2024038426A (en) | Device and method for controlling brain waves and cell activity using optical stimulation, and device for improving, preventing or increasing brain function | |
TWI734047B (en) | Light care system and light care method | |
US20220161049A1 (en) | Device for biostimulating phototheraphy | |
Chen | A theoretical approach for therapeutic artificial supplementary lighting in elderly living spaces | |
KR20120131253A (en) | Bed system for deep sleep | |
US11197975B2 (en) | Light health care system and light health care method | |
Laufer et al. | Psychophysiological effects of coloured lighting on older adults | |
CN204925532U (en) | Sharp healthy glasses of sleeping of eyeshield | |
WO2022196798A1 (en) | Device for controlling biometric function via light stimulation and operation method thereof | |
JP2015502813A (en) | Lighting signal, system, and method | |
RU124148U1 (en) | DEVICE FOR IMPACT ON HUMAN CIRCADIAN CLOCK | |
Boyce | Lemmings, light, and health | |
WO2023153478A1 (en) | Method for improving physiological conditions by photostimulation and device to be used therein | |
RU182615U1 (en) | DEVICE FOR FUNCTIONAL MANAGEMENT OF HUMAN ORGANISM CIRCADIAN CLOCK |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22771543 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 18551167 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202280022730.4 Country of ref document: CN Ref document number: 2023507199 Country of ref document: JP |
|
ENP | Entry into the national phase |
Ref document number: 20237035257 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020237035257 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2022771543 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2022771543 Country of ref document: EP Effective date: 20231019 |